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Abstract
Inflammatory muscle disease (myositis) is characterised by inflammation and a
gradual increase in muscle weakness. Diagnosis typically requires a range of clinical
tests, including magnetic resonance imaging of the thigh muscles to assess the
disease severity. In the past, this has been measured by manually counting the
number of muscles affected.
In this work, a computer-aided analysis of inflammatory muscle disease is
presented to help doctors diagnose and monitor the disease. Methods to quantify
the level of oedema and fat infiltration from magnetic resonance scans are pro-
posed and the disease quantities determined are shown to have positive correlation
against expert medical opinion. The methods have been designed and tested on
a database of clinically acquired T1 and STIR sequences, and are proven to be
robust despite suboptimal image quality.
General background information is first introduced, giving an overview of the
medical, technical, and theoretical topics necessary to understand the problem
domain. Next, a detailed introduction to the physics of magnetic resonance ima-
ging is given. A review of important literature from similar and related domains
is presented, with valuable insights that are utilised at a later stage. Scans are
carefully pre-processed to bring all slices in to a common frame of reference and
the methods to quantify the level of oedema and fat infiltration are defined and
shown to have good positive correlation with expert medical opinion. A number
of validation tests are performed with re-scanned subjects to indicate the level
of repeatability. The disease quantities, together with statistical features from
the T1-STIR joint histogram, are used for automatic classification of the disease
severity. Automatic classification is shown to be successful on out of sample data
for both the oedema and fat infiltration problems.
— J. Jack, September 2015.
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Chapter 1
Introduction
The domain of computer-aided analysis in medicine can be split into different
groups depending on the intended role.
Computer Aided Detection (CADe) takes the approach of a “second reader”,
which is essentially a second opinion, and uses visual markers to direct the atten-
tion of the doctor or radiologist. For instance, in Computed Tomography (CT)
colonography, CADe for polyp detection may function by ranking candidate re-
gions alongside the 3D rendering. The doctor decides whether the highlighted
regions need to be treated. CADe systems are of particular interest for invest-
igations that require a good deal of concentration or many small decisions, for
instance finding lung nodules and deciding if they are cancerous or benign.
Computer Aided Diagnosis (CADx) goes one step further and aims to take all
of the data available and output a diagnosis verdict. For instance, CADx systems
have been applied to differentiate benign and cancerous tumours in mammography
using (e.g.) texture features. In this case the system makes use of data that is
either difficult to perceive or would otherwise require many years of experience.
Systems may use non-imaging data as well, e.g. blood serum levels, age, sex.
In the literature the “CAD” term has a broad meaning and can refer to either
type of system. Most systems are designed for one disease only, eliminating the
need for differential diagnosis within the system itself. The doctor is ultimately
responsible for the overall decision, treatment, and progress review.
CAD has been applied extensively in some areas, for instance in the detection
of tumours and brain disorders. However, computer-aided approaches for the
detection of inflammatory muscle disease have received little attention. In the
case of myositis, there are only a few studies that detect or quantify the level of
disease from medical imaging investigation.
Doctors working with the Warwick Medical School in Coventry were interested
in using computer-aided analysis of their medical imaging investigations to help
make diagnosis and treatment decisions. This was primarily for the Idiopathic
1
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Inflammatory Myopathies (IIM), a group of diseases which are responsible for
inflammation build up in the muscles. Within this group are many individual
diseases with somewhat different presentations, including polymyositis, dermat-
omyositis, and inclusion-body myositis. Some of these have been linked with a
higher probability of malignancy.
The assessment of IIM could include a wide range of tests: bloods, muscle
strength test, electromyogram, patient history, biopsy, physical examination, and
Magnetic Resonance Imaging (MRI). All of the tests have some degree of vari-
ability: either in the way it is performed, or assessed. Muscle strength tests, for
instance, are difficult to perform reliably and requires patient compliance. For
blood tests, the Creatine Kinase (CK) level is known to be raised in those with
the disease, but it is also known to have normal levels in some histopathologically-
confirmed cases. That is to say, even when confirmed by microscope, patients with
the disease may have normal levels of CK. Therefore, for some tests, the result is
an indication but not a certainty. Overall, the doctor is looking for a pattern of
results that may indicate the disease, once other diseases have been ruled out.
When considering an IIM disease, MRI is always performed. Inflammation
(oedema) in the skeletal muscle can be seen and significant muscle damage may
be assessed. The doctor visually inspects each region of the leg on each slice.
Oedema must be identified as distinct from blood vessels and imaging errors.
Long-term muscle damage is also assessed by inspecting the amount of fat within
the muscles, which must be distinct from normal fat within the muscle. The cur-
rent standard way of assessing the severity of the disease is to count the number
of different muscles affected, as seen on transverse slices of the thigh. The doctors
were interested in using a computer-aided approach to get a more thorough quant-
itative analysis of the muscle disease using MRI. Even for an expert with decades
of clinical experience, it is sometimes difficult to assess the severity of disease, par-
ticularly when it is not severe. The hypothesis was that MRI contained enough
information alone (without other test results) to quantify and possibly diagnose
the muscle disease. By using a computer-aided approach, the variability of MRI
assessment may be reduced.
Treatment for IIM typically includes corticosteroids to reduce the level of in-
flammation, which also reduces further damage to the muscles. However, the
duration of treatment is difficult to determine and may depend on the treatment
response; patients may be re-scanned in order to assess changes in disease state. If
treatment is stopped too early, relapse of inflammation may occur. On the other
hand, the long-term use of steroids has serious side-effects. Therefore, a CAD
system that can monitor changes in disease state would have significant clinical
benefit.
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MRI machines work by sampling the magnetic resonance “echo” that is gener-
ated from atoms in the body when they are placed inside a magnetic field and a
Radio Frequency (RF) pulse has been applied (this process is explained in detail in
section 2.5). MRI is capable of producing very high Signal to Noise Ratio (SNR)
images but typically, in clinical situations, machine parameters must be used that
attain somewhat lower SNR images. This is due to the length of time the patient
must remain inside the scanner and be still. Elderly patients, or those with other
conditions, mean that image quality is sometimes poor. Some MRI sequences are
more prone to noise and imaging artefacts than others. Although some minimum
level of detail is required, any method of practical, clinical use must be robust
against poor quality scans.
With respect to the above, the aim of the research presented within the con-
text of this thesis is to provide a computer-aided analysis of inflammatory muscle
disease using MRI to help doctors in diagnosis and monitoring. The objectives
are to:
• Quantify the level of oedema and fat infiltration.
• Be robust despite suboptimal image quality.
• Measure changes in disease state over time.
• Be as automatic as possible.
The level of disease must be expressed as a decimal number which reflects
the total inflammation which can be seen in the MRI scan (c.f. an integer count
of affected muscles). Since there is no absolute ground truth as to the level of
disease, any disease metric constructed must have positive correlation with the
expert opinion of the doctor.
The system is required to work with MRI scans of a quality that would be
obtainable in a clinical setting. Although it is impossible to use images with
significant imaging artefacts, or those where the required protocol has not been
met, the system must be robust against poor SNR.
The detection and quantification of disease over a range of severities would
have clear clinical benefit, as would the ability to monitor the disease state over
time. It must do this with as little manual intervention as possible.
The current method to diagnose IIM requires a wide range of clinical tests,
which all have some degree of variation. The provision of a quantitative method
that can be applied to clinically routine scans is expected to reduce the overall
variation in the doctor’s diagnosis process, and may also help in disease monit-
oring. This would improve the level of care provided to patients with IIM. With
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a reduction in the variation of assessment, it is hoped that the number of clin-
ical tests required in the majority of cases will be reduced, saving time, money,
and lessening the strain put on the patient. The above observations provide the
motivation for the research presented within this thesis.
This thesis presents a number of contributions that originated from the research
conducted. They are:
• Semi-automatic methods to quantify oedema and fat infiltration for IIM
using MRI scans of the thigh which correlate with expert medical opinion.
• Visualisation of the expected presentation of disease state in the joint in-
tensity space for IIM.
• Design of feature vectors for the classification of disease state for IIM using
the joint intensity space.
In chapter 1 the problem domain has been briefly outlined. In chapter 2 the
necessary background is introduced, including a brief overview of the physics of
MRI acquisition. Chapter 3 presents a literature review of related research and
prerequisite topics, including the appropriate processing of MRI data. Chapter 4
details the pre-processing steps that are necessary to bring different patient scans
into a common frame of reference. The joint intensity space is also introduced.
In chapter 5 the database of MRI scans is used to show that the appearance of
the joint intensity space correlates with the disease state. This identification,
together with thorough data analysis, leads to the development of two disease
metrics. They are shown to have positive correlation with expert medical opinion.
Chapter 6 builds on the results of the previous chapter with the construction
of feature vectors for automatic classification of MRI scans. An out of sample
database is used to evaluate the results and the use of some selected feature spaces
are examined. Chapter 7 concludes with what has been achieved and discusses
the direction for future research in this domain.
Chapter 2
Background
2.1 What is myositis?
Myositis is a type of muscle disease (myopathy) that is characterised by inflamma-
tion and progressive muscle weakness. It is part of the Idiopathic Inflammatory
Myopathies (IIM) group. It is systemic, meaning that it affects the whole body,
not just the muscles.
There are different types of myositis, for instance polymyositis, dermatomyos-
itis, and inclusion-body myositis. The exact presentation tends to be different for
each disease but many of the symptoms and biomarkers overlap [14].
Estimates on the prevalence of myositis vary but it is approximately 8 in every
100 000 people in the general population [49]. There is no cure for the disease but
it is possible to reduce the level of inflammation by taking steroids in most cases.
How myositis starts is not understood, but it is thought that a combination of
environmental and immunological factors, with genetic predisposition, are in some
way responsible. Initial onset may develop after an infection, where the patient
gradually feels weaker over weeks, months, or years. Age of onset varies depending
on the exact disease.
The inflammation is an autoimmune response from the body and the sub-
sequent muscle damage causes cells to break open, releasing their content into
the extracellular fluid. Substances normally only found inside cells may now be
detectable in blood tests (e.g. aldolase, CK, aspartate aminotransferase), however
these substances are non-specific to myositis. As part of a normal healing pro-
cess, the damaged muscle cells are replaced by fat, which also makes the muscles
weaker. Myositis may be described as acute and chronic. Acute describes the
disease as active with inflammation. Chronic describes the disease as fat which
has infiltrated the muscle (infiltration). The terms are independent so the disease
could be chronic and acute concurrently.
5
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2.2 Types of MRI image
MRI machines normally produce images based on the magnetic resonance of hy-
drogen protons that are present in the material. Since human biology is largely
made up of water (H2O), this allows MRI to produce high quality images of tissues
in the body. It is also possible to produce more than one sort of image, depending
on the pulse sequence used to acquire the samples. Essentially, the type of pulse
sequence enhances or suppresses the signal from different types of material as a
result of their physical properties (e.g. [8, pp. 243–245]).
To use an analogy, this is similar to using a traditional film-based camera and
exposing with different types of film, for instance greyscale and infra-red film. It is
not the same as changing the exposure settings, since this only alters the intensity
response.
In reality, the MRI machine transmits a Radio Frequency (RF) pulse through
the material and then measures an echo some time later. This is explained in
more detail in section 2.5.
2.2.1 T1
The T1 pulse sequence measure the longitudinal relaxation of the magnetic mo-
ments [72, p. 7]. On a typical T1 image the fat and bone-marrow will appear
bright (hyperintense), water and muscle have an intermediate appearance, and
bone is dark (hypointense). An example of T1 scans are shown in Figure 2.1.
The quality of T1 images can be very high, although some scans investigated
have still suffered from noise.
2.2.2 STIR
The STIR sequence suppresses the signal from fat and is useful for imaging inflam-
mation because it generates a high signal [8, p. 244]. On a typical STIR image,
blood vessels and muscle surrounded by inflammation appear very bright, healthy
muscle has an intermediate appearance, and fat is dark or black. An example of
STIR scans are shown in Figure 2.1.
In contrast to T1 images, STIR images are likely to have low SNR and are
more susceptible to imaging artefacts such as ringing. It is possible to reduce the
noise by increasing the number of excitations used in the STIR pulse sequence,
however the length of time spent in the scanner must be reasonable for the patient
and so a compromise is made on the SNR.
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Figure 2.1: (a) and (b) show T1 and STIR scans of a myositis-positive patient.
Both are taken at the same location in the thigh. (c) and (d) are T1 and STIR
scans from a (healthy) control case. Note how diseased muscle in (b) appears
brighter than fat. In comparison, healthy muscle in (d) does not appear brighter
than the fat layer. In the T1 images (a) and (c), fat is always brighter than the
muscle. Note the presence of imaging artefacts, seen as light and dark patches, in
(a), (c) and (d).
2.3 DICOM format
Medical images are recorded in Digital Imaging and Communications in Medicine
(DICOM) format and pixel data are normally stored as a 16-bit single channel.
Due to differences in hardware, pulse sequence, and biology, there is no expec-
ted intensity range (which means that intensity values from one scanner cannot
be compared to another without some form of intensity standardisation). STIR
sequences typically have a smaller range than T1 sequences, but generally have
more than 256 unique intensities.
DICOM images also contain a library of information that can be looked-up to
help interpret and display the images. This metadata is recorded at the point of
acquisition. For instance, the information might relate to the MRI settings that
were used to acquire the images, the spatial resolution of each pixel, the time
of acquisition, patient details, slice location, etc. Note that, for this research,
personally identifiable data had been removed beforehand.
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Figure 2.2: Joint histogram examples for (a) myositis-positive and (b) healthy
patients. Both have 64 bins in each dimension. The horizontal axis, from left
to right, represents increasing T1 values. The vertical axis, from top to bottom,
represents increasing STIR values. No ROI has been applied.
2.4 T1 and STIR joint histogram
T1 and STIR images may be combined to generate a scatter plot and the resulting
clusters are thought to have diagnostic use [34]. When the scatter plot data is
summed into bins it may be called a joint histogram, or bivariate histogram (see
Figure 2.2).
A joint histogram can be generated by visiting pixels from the two images in
lock-step. Their joint intensity forms a pair (s, t), where s is the STIR intensity
and t is the T1 intensity. The joint histogram is then a tally of occurrences for all
such pairs. It is assumed the images are discretised prior to generating the joint
histogram. Due to the number of background pixels which have very low intensity,
the joint histogram typically has a very large concentration in the top-left corner
which can prove problematic when visualising the data. The example in Figure 2.2
has been log-transformed. In the case where a Region Of Interest (ROI) has been
applied, the joint histogram may be generated using only the pixels in the ROI,
generally revealing better structure.
Interpretation of the joint histogram is best done visually. Area D in Figure 2.3
is the approximate area of the histogram where diseased muscle is expected to
appear, characterised by intermediate T1 signal (water and muscle) and high
STIR signal (blood vessels and diseased muscle). Anatomical locations for the
thigh are shown in Figure 2.4. The high water concentration of diseased muscle
leads to this appearance in the joint histogram.
The appearance of joint histograms can vary considerably, even among healthy
subjects, owing to differences in the amount of fat, muscle and water present in
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Figure 2.3: Approximate areas of the joint histogram correlating to types of tissue.
(A) is the femur bone. (B) is normal muscle. (C) is fat, fascia, and bone marrow.
(D) is diseased muscle. Note that the top-left bin has high density due to the large
number of low intensity background pixels in both T1 and STIR images; an ROI
has not been applied.
Marrow
Femur bone
Fascia
Blood vessel
Muscle
Fat
Figure 2.4: Basic anatomy of the (right) thigh in the transverse plane. The view
is pointing towards the pelvis. On the MRI scans presented here, it would appear
on the left-hand side. For more detailed anatomy see [16, pp. 212–214].
the thigh. Without some method of intensity standardisation, it is not gener-
ally possible to compare histograms between patients because the images are not
calibrated such that a certain tissue always produces the same signal intensity.
Magnetic Resonance (MR) scans performed on the same scanner may be compar-
able, although the variation in magnetic field strength may be confounding.
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2.5 An introduction to the physics of MRI
A thorough understanding of how MRI works is outside the scope of this document.
However, a brief overview is given here so that a general understanding may be
gained. For detailed explanations please see [59; 28; 26; 8; 72; 29; 52].
The human body is made up of approximately 60% water (dihydrogen monox-
ide molecules) and therefore has an abundance of hydrogen atoms. Hydrogen
atoms are useful in MRI because they contain only one positively charged proton
which, depending on its direction of spin, generates a magnetic dipole moment,
north or south (Figure 2.5). Without the presence of an external magnetic field,
the magnetic dipole moments of hydrogen are arranged randomly and their net
magnetic field is zero.
Figure 2.5: A hydrogen atom has a net positive charge and generates a small
electric field depending on the direction of spin. The vertical arrows represent the
magnetic dipole moment.
When placed inside the MRI machine, the presence of a strong, fixed magnetic
field (denoted B0) causes the dipoles to become aligned with the magnetic field,
however their net magnetic field is still zero, since approximately half are pointing
north. Gradually over time, a small fraction of the magnetic dipole moments flip
to point in the same direction as B0, causing their net magnetic field (denoted
M0) to increase exponentially, up to some asymptotic maximum (Figure 2.6).
The direction of B0 is called the longitudinal direction (the Z axis), and two
other axes (X and Y) perpendicular to B0 define the transverse plane, with the Y
axis pointing up. With no other influences, M0 points in the same direction as B0
(Figure 2.7).
Protons placed in the magnetic field B0 also precess (wobble) around the axis of
B0 at a rate dictated by the Larmor equation, ω = γB, where γ is the gyromagnetic
ratio (a physical property of the nucleus) and B is the strength of a magnetic field
(Figure 2.8). For hydrogen, the gyromagnetic ratio γ is 42.6 MHz/T, which in a
1.5 Tesla MRI magnet gives a Larmor frequency of about 64 MHz.
If an oscillating Radio Frequency (RF) pulse is transmitted perpendicular to
B0, then the protons also precess around the direction of the RF wave (it is an
electromagnetic wave, therefore it has a magnetic component). This only occurs
when the frequency of the RF pulse matches the Larmor frequency ω, causing
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Figure 2.6: The effect of a magnetic field on the arrangement of magnetic dipole
moments (hydrogen protons). (a) With no external field the dipoles point ran-
domly. (b) When placed inside a static magnetic field (B0) the dipoles align with
the direction of the field, although their net magnetic field is still zero. (c) Over
time, a small fraction of the dipoles flip to point in the same direction as the
external field and their net magnetic field (M0) increases up to some maximum.
B0
X
Y
Z
Figure 2.7: Arbitrary axes for a patient in an MRI scanner.
B0
Figure 2.8: Precession of a hydrogen proton around the axis of B0.
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Figure 2.9: With a RF pulse, M0 is flipped 90 degrees into the X-Y plane.
resonance. The effect is that M0 is flipped into the transverse plane, said to be a
90 degree flip from the Z axis (Figure 2.9).
When the RF pulse is on and M0 has flipped into the transverse plane, the
protons have a higher energy state and are in phase with each other. Once the RF
pulse is turned off, then over time the protons lose their excess energy (transferring
it to the surrounding lattice of molecules) and will gradually align with B0, even-
tually becoming out of phase again. This exponential process is called relaxation.
T1 is thus called the longitudinal relaxation time, or spin-lattice relaxation time.
It is worth noting that T2 measures the decay of magnetisation in the transverse
plane.
A magnetic field gradient may be generated by using a pair of coils such that
the field is (e.g.) north at one end of the machine and south at the other end of
the machine, causing a sliding scale of magnetic field strength from one end to the
other, with a centre point where the field is zero. One such gradient is denoted GZ ,
which is in the same direction as B0. This essentially causes B0 to vary (e.g.) from
1.4 T to 1.6 T, which in turn means the rate of precession of hydrogen through
the body varies from about 59.6 MHz to 68.2 MHz (Figure 2.10). Thus, the range
of frequencies transmitted in the RF pulse can select which protons are flipped
(both the position and thickness of the image slice).
The signal of M0 is measured using RF coils, possibly the same coils which
generated the RF pulse. Time to Echo (TE) is the amount of time to wait after
the RF pulse before measuring the signal. Time to Repeat (TR) is the amount of
time to wait between RF pulses.
Readout is the process of taking samples of M0 over some small period of
time. The readout signal represents the sum of signals from protons resonating
throughout the whole slice (not just a single voxel).
To gain spatial information in one dimension, another magnetic field gradient
GX is applied along the X axis (perpendicular to B0) during readout. For instance,
for a 3×3 matrix of voxels in a slice, protons in the left column would have a slightly
CHAPTER 2. BACKGROUND 13
60MHz 64MHz 68MHz
65.95MHz 66.05MHz
Larmor frequency
B0
Magnetic field
strength (Tesla)
GZ
1.5T
-0.1T
+0.1T
Summation:
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Selected slice
Figure 2.10: Slice selection is achieved by using the addition of a linear field
gradient (generated by e.g. Maxwell coil pairs) to alter the precessional frequency
of hydrogen through the body in the direction of the Z axis.
lower precessional frequency, the middle column would remain as before, and the
right column would have a slightly higher precessional frequency. This is called
frequency encoding. After M0 is sampled during readout, a decomposition of the
signal would reveal 3 different frequencies. Immediately after readout is complete
GX is switched off.
So far it has been possible to select hydrogen protons using GZ and a RF pulse
(for slice selection), and later using GX during readout for frequency encoding
(column information). It is not possible to just use frequency encoding in both
X and Y directions at the same time, since this would mean many pixels would
be represented by the same frequency. To isolate the final dimension requires a
process called phase encoding, which must be repeated many times because the
MRI machine is not able to measure phase directly (otherwise each pixel would
be uniquely encoded by frequency and phase).
Phase encoding starts by using another magnetic field gradient GY , applied
along the Y axis for a short period of time, just after the RF pulse, but before
readout. At this point, all protons in the slice still have coherent phase. Consider
the 3×3 matrix again. As the gradient GY is applied, the precessional frequency
is higher for those protons in the top row voxels, remains unchanged in the middle
row, and is lower for those in the bottom row. The change in frequency also means
a change in phase (positive for higher frequency, negative for lower frequency).
After GY is switched off, the frequency for all protons in the slice will again be
the same because they experience the same magnetic field strength. However, the
phase change that was induced in each row is retained, such that each row has
a distinct phase. The length of time that GY is turned on controls the amount
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Figure 2.11: Example of an MRI pulse sequence diagram. Time goes from left to
right.
of phase change between rows. The process of phase encoding can only be done
once per TR and therefore the whole process must be repeated a number of times,
equal to the number of rows in the matrix, each time using a different field gradient
GY . Note that when stronger field gradients are used the overall signal amplitude
becomes weaker due to increased dephasing effects.
The steps so far are: slice selection, phase encoding (rows), and frequency
encoding (columns). A simplified example of an MRI pulse sequence digram is
shown in Figure 2.11. The resulting precession of hydrogen protons means there
is a changing magnetic field flux which can be measured by the receiver coils (a
moving field induces an alternating current in the coil). The samples of this signal
are stored in k-space, which is a complex matrix. During readout, the samples are
stored in a single row of k-space. The process is repeated with a different phase
encoding gradient and the samples are stored in the next row of k-space. Once
every row in k-space has been filled, all the necessary data for the final image has
been collected.
Going from left to right in k-space represents frequency. Going from top to
bottom in k-space also represents frequency because the change in phase encoding
gradient (GY ) at each step is equivalent to a change in frequency. Therefore
it is possible to use a two dimensional Fourier Transform (FT) to get real and
imaginary images from the spatial frequency domain.
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Normally, the image received from the MRI scanner is a magnitude image,
m =
√
r2 + i2, where r is the real component, i is the imaginary component, and
m is the final image.
The MRI machine may perform other pre- or post-processing steps. For in-
stance, signals picked up at the receiver coils are subject to the inverse square law,
and therefore signals from objects closer to the receiver coils are stronger. The
MRI machine adjusts for this effect automatically.
2.6 Scanning protocol
Slices are taken in the transverse plane, starting from the pelvis and moving to
just above the knee (Figure 2.12). Since myositis is systemic, the disease could
be visible in any muscle, however a large bulk of muscle is preferred because
the associated inflammation can appear in patches. Therefore slices taken close
together are less useful than those spread apart. Since acquisition is done in a
clinical setting, the exact position will be determined by an experienced radiologist.
T1 and STIR taken
at each location
Figure 2.12: Approximate slice locations on a patient.
Slice thickness was 8mm with a 2mm gap between images. For all databases
a set of 6 contiguous slice pairs were chosen to start just below symphysis pubis
and ended before the top of the knee. The Field of View (FOV) was typically
40cm×40cm. Pixel spacing was between 0.74mm and 1.04mm.
2.7 Cohorts and acquisition
The term image pair (or slice pair) will refer to one T1 image and one STIR
image that have been taken in the same slice location, for the same patient, at
approximately the same time. A case will refer to a set of image pairs over some
contiguous region of the thigh. Scans will normally have between 6 and 12 image
pairs. Many slice locations are sampled because myositis can be “patchy” and
therefore it may not be visible on all slices. Indeed, if a biopsy is to be taken, the
appropriate region may be located on MRI first.
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The cases in each database (detailed below) have exactly 6 slices. Acquisitions
came from 3 different 1.5 Tesla MRI scanners: Optima MR450w, Optima MR360,
and Gyroscan Intera.
2.7.1 Training database
As part of a clinical trial, 12 symptomatic (volunteer) patients and 9 asymptomatic
controls were scanned from 2013 to 2015. These scans followed a strict acquisition
protocol.
A small historical database of 10 patients was also utilised, taken between
2001 and 2005. The acquisition protocol for these scans were similar to the cur-
rent protocol, although there was a greater range of TR and TE times. The
essential aspects were the same: slice locations for T1 and STIR were aligned and
a contiguous set of image pairs were manually selected from the same body region
as newer scans.
The variation in protocols were viewed as a way to ensure that the methods
employed were robust against small changes in acquisition parameters. It should
be noted that different MRI machines are not always capable of exactly the same
parameters. The image quality is not just dictated by the sequence parameters
but also the individual scanner.
2.7.2 Out of sample database
A further 12 symptomatic patients were scanned in 2015 and were used as an out
of sample database. These followed acquisition protocol. These scans were not
made available until near completion.
2.7.3 Re-scan database
In some instances, a subject was scanned more than once. Re-scans occurred
between 2013 and 2015. In summary: 1 control subject and 1 symptomatic patient
were rescanned during the same session. 2 symptomatic patients were scanned 3
times on different occasions. 1 symptomatic patient was scanned on 2 different
occasions.
2.7.4 Expert grading
Scans in the training and out of sample databases where graded by a medical
expert. One grade measures the severity of acute disease (oedema) while the
other grade measures chronic disease severity (infiltration). Table 2.1 shows the
ordinal scale used for both severities.
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Grade Ordinal value Meaning
Normal 0 No current disease
Mild 1 Diseased
Moderate 2 Diseased
Severe 3 Diseased (densely packed/widespread)
Table 2.1: Ordinal grading scale for acute and chronic disease.
2.8 Conclusion
This chapter has presented the medical, technical and theoretical background
upon which this research has been built. In the next chapter, a detailed review
of existing literature is carried out, to cover important topics, particularly with
regards to the appropriate processing of MRI data.
Chapter 3
Literature Review
In this chapter, a review of the literature is presented. Note that, due to the very
narrow problem domain, it has not been possible to review a great quantity of
very similar work. However, algorithms used in the detection and diagnosis of
different diseases and other related published literature have been reviewed.
3.1 General surveys and background
Wang and Summers [71] give a broad overview of machine learning and CAD
in the radiology setting, including segmentation, registration, cluster analysis,
neural networks, etc. Cluster analysis has many applications in radiology and the
k-means clustering, hierarchical clustering, DBSCAN, and mixtures of Gaussians
methods are reviewed [71, pp. 937–938]. Registration and optimisation is explained
to be part of machine learning [71, pp. 941–942]. Segmentation methods used in
medical imaging are also reviewed by [17].
Terms used in the literature are Computer Aided Detection (CADe) and Com-
puter Aided Diagnosis (CADx), both of which may be referred to as CAD. CAD
aims to improve diagnostic accuracy, reduce reading time, or increase detection
sensitivity. Usually, CAD systems are designed to deal with only one specific dis-
ease [71, p. 942]. CADx has been used extensively in particular areas of medicine,
for instance: breast tumour detection and diagnosis, polyp detection in colon can-
cer, and pulmonary embolisms [71, pp. 942–943]. The brain and liver have been
the subject of increasing research [15, p. 201]. More recently, MRI and contrast-
enhanced MRI have been used in the diagnosis, prediction, and monitoring of
rheumatoid arthritis [6].
Note that the distinction between detection and diagnosis lies in how the in-
formation is likely to be used: detection normally refers to CAD systems where
the algorithm is viewed as a second reader and its performance is measured in
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conjunction with a physician, whereas diagnosis systems (CADx) are considered
standalone and therefore the required sensitivity is much higher [15, pp. 200–201].
Registration is a crucial step for any process that will combine data from
two or more sources [20, p. 1381]. In the context of medical image registration,
unregistered images may lead to an incorrect diagnosis being reached [43, p. 236].
Since there is much published literature on the subject of registration, the
review has focused on published surveys. Registration as a general process is
reviewed by [77]. Medical image registration is reviewed by [1; 43; 32; 51; 31].
In particular, [31, pp. 276–277] looked at multimodal medical image registration
and found that Correlation Coefficient (CC), Correlation Ratio (CR), and Mutual
Information (MI) were the most popular intensity-based measures. CC assumes
some linear relationship between the intensities in the images. CR uses any func-
tional relationship, while MI uses the statistical dependency between intensity
values.
Using CR for the registration of multimodality images was first proposed by
Roche et al. [64]. Using the brain scans of ten patients, Roche et al. found that CR
had a lower mean registration error than MI for T1-to-T2 inputs. They argued
that, since tissues are never represented by a single intensity value, it is important
to use a measure that considers nearby intensities in the intensity space and this
property is not utilised by MI.
Despite this, MI has been used extensively to register both multimodal and
monomodal images [23, p. 28].
Kassner and Thornhill [42] reviewed the use of texture analysis for neurolo-
gical MR applications with particular focus on CADx. They first point out that
experienced radiologists spot patterns in brain scans and rely on their judgement
to make a diagnosis, but that inevitability there are components of human vari-
ability and differences in visual perception, and that these can be mitigated by
using automatic tools. For neurological applications, it was hypothesised that a
“texture signature” could be found to describe different diseases by examining
the changes in gray-level transitions found in MR images. Statistical descrip-
tions of gray-level changes include first-order (e.g. mean, variance, gradients), and
second-order measures such as Gray-Level Co-occurrence Matrix (GLCM) and
Run-Length Matrix (RLM). The GLCM is a tabulation of a particular relationship
occurring between pairs of pixels in the input image for the number of gray-levels
present. Often the input image is quantized such that a relatively small number
of gray-levels exist (e.g. 8) to prevent sparsity. The image may then be used with
some relationship considering pixels that are at distance d = 1 pixel away and at
angle θ = 45◦, resulting in an 8× 8 matrix. Multiple GLCMs can be constructed
systematically e.g. d = 2 and θ = 0◦, 45◦, 90◦, 135◦ and the resulting matrices av-
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eraged element-wise to give a direction-invariant GLCM for d = 2. They note that
14 textural features can be computed on the GLCM (e.g. contrast, correlation [42,
Appendix Table 2]). RLM tabulates the number of consecutive pixels (i.e. in a
run) for a given direction: Pθ(i, j) for gray-level i and run-length j, and 5 features
can be computed on it [42, Appendix Table 3]. They suggested that both GLCM
and RLM be normalised by dividing by the total number of matrix entries.
Kassner and Thornhill [42] also describe the problem of data “over-fitting”,
where the feature vector is large enough to describe the noise present in the input
data and therefore any possible classification. They go on to briefly describe
feature space reduction, classification methods, and cross-validated evaluation.
Cross-validation (k-folds) is described as partitioning the data into training and
testing sets. The training data is used to train the classifier and its performance is
scored on the testing data which is an “out of sample” evaluation. The partition is
“rotated” such that the testing data is different and the process performed again
until all rotations have been tried. The overall success is the average of the test
scores. The term “folds” refers to the split between training and testing data and
the number of rotations. For instance, k = 10 folds would describe a ratio of 9:1
(training to testing, respectively) with 10 rotations, and the overall performance
scored out of 10.
3.2 ROC analysis
Excellent introductions to the topic of Receiver Operating Characteristic (ROC)
curves, their use in medicine, and with classifiers, has been given in [18; 25; 69].
ROC curves have been used in many different domains to assess the classification
ability of a certain method and is therefore a very useful comparison tool.
The ROC curve plots the True Positive Rate (TPR) over the False Positive
Rate (FPR). An equivalent interpretation is sensitivity on the ordinate and (100-
specificity) on the abscissa. Points in ROC space represent a trade-off between
the benefit of correctly identifying positive instances versus the cost of incorrectly
labelling negative instances as positive [18].
To take an example, the output from a Naive Bayes classifier is the probability
of the instance belonging to a certain class. Given multiple instances, an ROC
curve may be generated by considering the TPR and FPR which is obtained for
a set of thresholds, e.g. “probability ≥ ti”. The raw probabilities do not have
an effect on the ROC curve, only their relative ordering (i.e. their rank), and
therefore, rather than probabilities, any suitable scoring mechanism that expresses
confidence could be used. Table 3.1 and Figure 3.1 show the hypothetical output
from a Naive Bayes classifier and its associated ROC curve. The diagonal dashed
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line represents a coin-toss classifier that predicts no better than random.
The Area Under the Curve (AUC) of the ROC, also called Area Under the
Receiver Operating characteristic Curve (AUROC), is important because it rep-
resents the probability that a randomly chosen positive instance is ranked higher
than a randomly chosen negative instance [18] and it is mathematically equivalent
to the Wilcoxon statistic W [25, pp. 30–31]. Therefore the area under the ROC
curve is a useful metric for comparing classifier performance. A random coin-toss
classifier has a theoretical AUROC of 0.5 and therefore any classifier of interest
would normally be above this value.
No. Truth Score t TPR FPR
+∞ 0.0 0.0
1 P 0.92 0.92 0.2 0.0
2 P 0.91 0.91 0.4 0.0
3 N 0.83 0.83 0.4 0.2
4 P 0.72 0.72 0.6 0.2
5 P 0.50 0.50 0.8 0.2
6 N 0.49 0.49 0.8 0.4
7 N 0.34 0.34 0.8 0.6
8 N 0.33 0.33 0.8 0.8
9 P 0.28 0.28 1.0 0.8
10 N 0.11 0.11 1.0 1.0
Table 3.1: Example of scores from a clas-
sifier.
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Figure 3.1: Example construction of
an ROC curve.
3.3 Imaging artefacts in MRI
There are a wide variety of MRI sequences which aim to express certain properties
of the tissues. For instance, the STIR sequence suppresses signal from fat tissue
but enhances signal from oedema [53, p. 732]. However, some sequences are more
susceptible to imaging artefacts and distortions than others. The STIR sequence
suffers from poor SNR and imaging artefacts can be produced as a result of e.g. pa-
tient movement, and circulating blood (pulsation) [53, p. 732]. Patient movement
may cause imaging artefacts for any sequence but it is not expected to be a major
problem when scanning the legs because it is distant from the ongoing movements
of the lungs and heart, although some patients may be unable to remain still (e.g.
the elderly). The circulation of blood, particularly through the arteries (e.g. any
of the femoral arteries, see “Blood vessel” in Figure 2.4), are expected to cause
“zipper” artefacts on the STIR images, vertically or horizontally (depending on
the phase encoding direction of the scanner). Brown and Semelka [8, pp. 113–117]
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explained that circulating blood can also produce ghosting artefacts.
T1 images may also contain the imaging artefacts discussed previously but
are generally of better quality. Both T1 and STIR images may show “lighting”
artefacts. For instance (a) and (c) in Figure 2.1 (page 7) clearly show anisotropy
effects in the fat layer, which theoretically should have homogeneous intensity for
the same tissue type. This may be a result of the inhomogeneous static magnetic
field used in MRI machines, although, as explored later, there are a plethora of
interacting physical phenomena that cause deviations from the “true” image.
Since all imaging sequences used in MRI use Radio Frequency (RF) electro-
magnetic pulses, imaging artefacts can result from RF interference from other
equipment. This could appear on any sequence, and has been seen on T1 and
STIR.
As explained in [5], the limitations of the electronics and hardware of the MRI
machine prevent perfect sequencing in terms of (e.g.) timing and magnitude. The
performance of the RF receiver coils depend upon its exact geometry and physical
construction. The gradient fields used for slice selection, frequency encoding, and
phase encoding may also suffer from non-linearity, which can cause geometric
distortion and eddy currents.
3.4 Intensity correction for MRI
Unlike other imaging techniques such as CT, the intensity from MR is generally
uncalibrated [56; 57]. For instance, the intensity value of fat tissue for a patient
scanned on one MRI unit may not result in the same intensity for the same patient
on a different unit, even when using similar sequence parameters [63]. This is
due to differences in the machines [57; 5] and their magnetic field inhomogeneity
[70]. Indeed, Nyu´l, Udupa and Zhang [57] stated that intensity values cannot be
expected to be consistent even if the same patient and the same scanner unit were
used.
The effect of the inhomogeneous magnetic field may exacerbate these problems.
If a patient is scanned twice on the same unit on subsequent days, the patient’s
position relative to the magnetic field may not be the same, and therefore the
intensity response may be different for the same tissue. However, other factors are
also responsible.
Tong et al. [66] presented intensity correction as two separate correction prob-
lems to consider: non-uniformity refers to the inhomogeneous nature of the mag-
netic field (and the possible effects of other physically interacting phenomena),
while non-standardness refers to the problem that tissues do not have a standard
intensity value across all slices or from difference scanners.
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To help understand the complex nature of MRI, the literature has been ex-
plored. It has been shown that the RF signals used in acquisition are absorbed
by human tissue and as a result the core body temperature is elevated [48]. It has
also been shown that temperature has an effect on T1 relaxation times and thus
the signal intensity [58], and conversely it has been shown that it is possible to
use MRI to monitor temperature [35]. Consider also that MR samples are taken
in the spatial frequency domain [26], and therefore one can see that any change in
the physical property of the material being scanned, in any single voxel, results
in a global change for all pixels after application of the Fourier Transform (FT).
Most importantly, Belaroussi et al. [5] explained that the physical proper-
ties and shape of the material being imaged significantly affected intensity non-
uniformity due to RF standing waves and penetration [5, p. 235].
In summary, the literature has shown that some form of intensity correction
(both for non-uniformity and non-standardness) is required when working with
MR data, particularly for quantitative measurement [33; 5].
3.4.1 Non-uniformity correction
Belaroussi et al. [5] and Vovk, Pernus and Likar [70] review methods for non-
uniformity (inhomogeneity) correction. Vovk, Pernus and Likar [70] divided the
methods into two main groups of prospective and retrospective. Prospective meth-
ods require additional equipment during acquisition: a phantom is a fixed material
used for reference. Retrospective methods are image processing techniques applied
in a post-processing stage [70].
In the literature, correction of non-uniformity is often modelled by a multiplic-
ative field (sometimes called a bias field) over the image, with the form
v(x) = u(x)f(x) + n(x), (3.1)
where for some location x, v is the acquired signal, u is the ideal signal, f is
the bias field component, and n is a noise component (e.g. [12; 5]). If the noise
component n is ignored then the log transform separates u and f components to
be an additive relationship such that
vˆ = uˆ+ fˆ (3.2)
where vˆ = log v, uˆ = log u, and fˆ = log f (e.g. [70; 12; 65]).
Now that the mathematical form has been introduced, a brief overview of some
of the approaches used in retrospective methods will be discussed, as outlined in
[70]. Filtering methods assume that the bias field is a slowly-varying function
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over the image. One such technique is called homomorphic unsharp masking,
where the input image is divided by a low-pass version. Surface fitting methods
use a parametric surface (e.g. using polynomials or splines) to model the bias
field. Segmentation-based methods view intensity inhomogeneity as a segment-
ation problem, which essentially minimises the scatter of tissue classes, with or
without a priori knowledge of the expected tissue intensities. Histogram based
methods are fully automatic, requiring no a prior knowledge.
An outline of all proposed methods is not possible, however some specific meth-
ods from the literature will now be discussed.
Sled, Zijdenbos and Evans [65] proposed the N3 method which is a histogram
based method and stands for “non-parametric non-uniformity normalization”. N3
works by considering the probability density functions of the variables in Equa-
tion 3.2 such that
V = U ∗ F (3.3)
where ∗ is the convolution operator, V = pdf(vˆ), U = pdf(uˆ), F = pdf(fˆ), and
are approximated to be independent random variables. Sled, Zijdenbos and Evans
[65] go on to explain that the high frequency component of U represents the detail
of the true signal which is blurred due to the presence of the bias field (density
function F ). In an iterative process, the frequency content of U is maximised.
The approach proposes a sharpened distribution of V on which the bias field fˆ
(constrained to be smoothly varying) is estimated that also has density function U
approximately close to the proposed distribution [65, p. 88]. This problem would
be intractable (considering all possible fields) but the bias field search space is
reduced by approximating F as a Gaussian.
Tustison et al. [67] proposed an update to the N3 method called N4ITK. In this
update, a new (parallelisable) B-spline estimator is used, and on each iteration the
residual bias field is estimated (as opposed to the whole bias field, as was done in
N3). They state this allows for dense control points, for the correction of high-
Tesla fields [67, p. 1311]. N4ITK was made publicly available as part of the Insight
segmentation and registration ToolKit (ITK).
Ji et al. [41] describes another segmentation based method for non-uniformity
(inhomogeneity) correction. Anisotropy effects in the input image were corrected
by modelling the bias field as a multiplicative component of the true image,
I = b · J + n (3.4)
where I is the observed image, J is the true image, n is Gaussian noise, and b is
the bias field modelled by the linear combination of a number of orthogonal poly-
nomials (notice the similarity with Equation 3.1). Tissue class membership was
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determined via a generalised rough fuzzy c-means algorithm which had positive,
boundary, and negative regions per class. Each pixel in the image had an asso-
ciated intensity distance vector which was calculated by considering the average
intensity distance for a neighbourhood around the pixel to all unique intensities
in the image. Global thresholds are established by calculating the average min-
imum distance of all distance vectors and the same for the average maximum of
all distance vectors. These thresholds were used to determine positive, boundary
and negative regions for each class. Pixels in a positive region definitely belong
to one class, and those in a negative region are excluded from a given class. The
goal of the generalised rough fuzzy c-means algorithm was to then minimise an
objective function representing the spread of intensities for all classes for all pixels
in a positive or boundary region [41, p. 647].
3.4.2 Intensity standardisation
Nyu´l and Udupa describe their method of intensity standardisation which was
developed over several publications [55; 56; 57] where the core idea has remained
constant. It is assumed that it is desirable to remove the “tails” of the histogram
which are considered outliers or a result of MR artefacts [55, p. 596]. In a training
step, a landmark in the histogram space is computed (e.g. the mode, median, or
percentile) and transformed to a standard intensity scale space using upper and
lower percentiles (defining an Intensity of Interest (IOI) range). The mean of the
transformed landmarks µmean is calculated. They note that this only has to be
done once. In the second step, intensities of the input images are transformed by
mapping piecewise linearly over the landmarks to the standard intensity space.
Note that more than one landmark may be used, for instance when the histogram
is bimodal, in which case there are two mean transformed landmarks found in the
training step. They note that the histogram shape, and hence the selection of
landmarks, is dependent on the imaging sequence and the body region.
Robitaille et al. [63] designed brain-specific histogram landmarks for use with
the method of Nyu´l and Udupa. They use the Alzheimer’s Disease Neuroimaging
Initiative (ADNI) database, which is a large mutlicentre database of brain scans
and associated medical data of healthy controls and Alzheimer’s Disease (AD)
patients. Robitaille et al. explain that the problem of intensity standardisation is
a particular problem in large multicentric databases, such as ADNI. They identify
landmarks in the histogram space specific to different brain tissues and show the
subsequent standardisation has less error than using the L4 landmarks set (de-
scribed in [57]). They noted that in some domains “overstandardizing” [63, p. 7]
may be a problem, depending on the pathology in question.
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Hellier [27] used a Guassian mixture to model the intensity histogram from
(e.g.) two images and the parametric correction was computed as a least squares
problem. In this work, there is no requirement that the images be registered.
Ja¨ger et al. [39] approached intensity standardisation as a minimisation prob-
lem of the distance between probability density functions of the acquired sequence
images (see also Ja¨ger and Hornegger [38]). The multidimensional joint histograms
are aligned non-rigidly using a registration method (e.g. MI, sum of squared differ-
ences, normalised cross correlation)[39, p. 273]. Joint histograms were equalised
prior to registration in order that low-probability tissues were raised in the joint
histogram space and high-probability tissues were suppressed. This was done to
ensure the registration was not biased towards high-probability tissues [38, p. 139].
Still, Ja¨ger and Hornegger [38] note that tissue classes with few voxels may not
be registered reliably (referring to histogram space) and is also dependent on suc-
cessful inhomogeneity correction [38, p. 139].
3.4.3 Discussion
From reviewing methods for non-uniformity correction and intensity standardisa-
tion, it is clear that both are important steps but it is not clear in which order
they should be corrected.
Madabhushi and Udupa [50] used nearly 4000 MR datasets to explore the re-
lationship between intensity standardisation and inhomogeneity correction. Their
results indicated that inhomogeneity correction methods were indifferent to whether
the input was standardised or not, but intensity standardisation methods per-
formed better on inhomogeneity corrected input. Therefore inhomogeneity cor-
rection should precede intensity standardisation.
Considering all the work reviewed for intensity correction, it can be seen that
working with MRI requires careful adjustment to reduce inhomogeneity and bring
scans into a common frame of reference using intensity standardisation (with care
regarding the specific pathology being considered).
3.5 Using MRI for disease detection
In this section, very important non-automated MR research for myositis and other
muscle diseases is presented.
In the general case, MRI has been identified as a suitable imaging modality in
the evaluation of soft tissue abnormalities [4, pp. 253–254], which would include
the IIM disease group.
Kim et al. [45] found that total signal intensity (as scored by a visual scale
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on affected muscles) was mildly associated with clinical findings such as aldolase
(r = 0.363, p < 0.004), histopathological scoring (r = 0.339, p < 0.05), and
muscle power (p < 0.05). These results were for dermatomyositis and polymyositis
patients versus a control cohort.
Van De Vlekkert et al. [68] stated that using MRI increased the accuracy of
diagnosis for Idiopathic Inflammatory Myopathies (IIM). Using only muscle biopsy
tests to diagnose IIM resulted in a False Negative Rate (FNR) of 0.23. Biopsies
with positive MRI findings (hyperintense signal) reduced the FNR to 0.19. Using
MRI when biopsies were negative resulted in a FNR of 0.06.
Hutchinson [34] has shown that the combination of T1 and STIR signal may
identify suspected disease in myositis.
Fischmann et al. [19] demonstrated that the change in T2 relaxation over
time was significantly higher in patients with oculopharyngeal muscular dystrophy
(p = 0.01) compared with controls. Longer time intervals between scans suggested
larger changes in T2 relaxation.
Kim et al. [44] showed that non-quantitative fat infiltration scores (visually
graded on a set scale) correlated with mean T2 relaxation times (p < 0.001) for
skeletal muscle in Duchenne muscular dystrophy [44].
Note that T2 relaxation times are computed with a least-squares model from
multiple echoes and represent a purely quantitative figure. Although useful for re-
search, calculating this quantity requires long scanning times, and is not performed
in the standard protocol for myositis.
In Herlidou et al. [30], nine senior radiologists were presented with MRI scans
of the thigh and asked to give five different texture scores (coarseness, contrast, fat
infiltration, complexity, and force) for which definitions had been provided. The
scans were of 14 normal subjects and 17 patients suffering from muscular dystrophy
but the radiologists did not have access to any related diagnostic information
(muscular dystrophy must be considered as distinct from myositis). Some scans
were presented twice to measure intra-observer variability. The variability of the
scores was significant in both the inter-observer (p < 0.001) and intra-observer
cases [30, pp. 1395–1396]. This shows the inherent subjective nature of visually
assessing muscle diseases using MR images.
In summary, this section has shown encouraging evidence from non-quantitative,
semi-quantitative, and quantitative methods, that MRI contains substantial data
applicable to muscle diseases, which may be used in computer-aided analysis.
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3.6 Quantification of myositis
A literature search for published articles relating to the automatic detection or
diagnosis of myositis was conducted and only one article was found.
Bartlett et al. [3] used the histogram of pixel intensity values from STIR images
to quantify the amount of diseased muscle. The method requires an initial estimate
of the pixel intensities representing healthy tissue, which was either taken as the
average of pixel intensities taken from a normal subject, or the manual placement
of a small ROI on healthy muscle. A Gaussian curve is fitted to the peak intensity
on the histogram, which identifies the distribution of healthy muscle, and this
is subtracted from the histogram. Due to diseased muscle typically appearing
brighter on STIR images than healthy muscle, the diseased muscle is assumed to
be pixels with intensities to the right of the Gaussian. However, different histogram
shapes are to be expected, since patients have different proportions of healthy and
diseased muscle, and as the authors explain [3, pp. 185–187], in some cases a
healthy peak could not be identified in the histogram. In this situation the peak
with the maximum intensity was taken as the diseased muscle, a Gaussian curve
fitted to the peak (using a pre-determined HWHM value), and then subtracted
from the histogram. The remaining, most intense peak, is then assumed to be
healthy muscle and a Gaussian curve is fitted to this peak. In either case the
quantity of diseased muscle can be estimated by the residual diseased histogram.
Bartlett et al. used a phantom filled with a tissue-simulating solution with five
normal subjects to assess the variability of the healthy tissue peak in the histogram.
The standard deviation of the intensity value for the identified peak was found
to be 6.3% for ten scans (five normal subjects scanned twice). This is used as
justification that other scans in the study would have similar intensity values for
healthy tissue. 6.3% is assumed to be relative standard deviation, RSD = 100σ
µ
(a scaled version of the coefficient of variation).
Two measures of the disease were determined: extent and intensity. The extent
of the disease is the number of pixels classified as diseased as a percentage of the
pixels classified as diseased or healthy. For disease intensity, the x-axis of the
residual diseased histogram is linearly scaled such that the healthy tissue peak
corresponds to a value of 100. The intensity measure is then calculated as the mean
of the pixel intensities in the residual diseased histogram (values above 100). The
authors note that often a few pixels have very high intensities due to the presence
of blood vessels and these do not represent diseased muscle. Therefore, histogram
bins are excluded from the calculation when they contain less than 2% of the
number of pixels found at the healthy tissue peak.
Bartlett et al. gave results as Area Under the Curve (AUC) considered with
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different clinical categories as ground truth (Table 3.2). Separating remission vs.
non-remission gave 86% sensitivity and 83% specificity.
Test Visual score CMI
Remission vs. mild/moderate/severe 0.94 0.93
Remission/mild vs. moderate/severe 0.92 0.92
Remission/mild/moderate vs. severe 0.68 0.65
Table 3.2: Data from Bartlett et al. [3]: AUROC considered
for different clinical categories.
The main concern with the approach taken is that it depends on the quality
of the Gaussian fit to the underlying distribution of muscle tissue (normal, and
diseased) in the MR image. It is possible that a different distribution would fit
the distribution better, something that might take into account the “tails” of the
distribution, which may be an important presentation of the pathology in myositis
(c.f. [55, p. 596]).
From the discussion in section 3.4, it is clear that correction of non-uniformity
would be of benefit (note that publication was in Feb. 1999, although correction
methods had been published e.g. [12; 65]).
The technique requires that a peak be found in the intensity histogram, and
in cases where there is no definitive peak, the selection of a peak becomes some-
what arbitrary (cases with approximately 50% diseased pixels may have broad
distributions). This is a greater concern when considering multiple MR scanners.
The intensity measure of the disease is sensitive to changes in the location of the
healthy muscle peak.
By definition, the histogram as presented in Bartlett et al. [3, p. 185] can only
occur in the most severe cases; when the number of hyperintense pixels exceeds the
number of pixels considered healthy. In the training and out of sample databases,
all subjects had less than 1
2
oedema (of total muscle). Although research in all
stages of disease can be of use, it is of clinical and practical benefit to have methods
which focus on the lower severity range.
To quantify the level of fat infiltration, STIR is unsuitable because the sequence
is designed to suppress signal from fat. It is already known that the T1 image can
adequately identify fat infiltration for myositis [34; 30, p. 1396].
3.7 Detection of neuromuscular diseases
Ko¨nig et al. [46] used a computer-aided approach with Ultrasound (US) acquis-
itions of the upper arm to detect muscle disease. Between 2 and 4 images were
acquired on 7 healthy subjects and 11 subjects with myositis. For each image an
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ROI was manually defined and subsequent processing was performed on this region
only. Several different features were selected to represent the textural appearance
of the disease on the scans. This included the mean, standard deviation, skewness,
kurtosis, and entropy of the intensity histogram. Other features were based on
the GLCM and two-dimensional discrete wavelets. The initial feature vector had
375 elements. Feature space reduction was performed using supervised principal
component analysis, of which the top 5 features were selected for training.
Classification was performed with 3 different methods: k nearest neighbour,
Fisher’s linear discriminant, and linear Support Vector Machine (SVM). Results
indicated that the SVM classifier had fewer errors compared to the others. Using
the average of two ROIs, the system attained 90% sensitivity and 84% specificity.
It was assumed that US highlights the disease based on the replacement of
muscle by fat [46, p. 1493], as caused by the disease. However, this represents
long-term (chronic) disease, not active (acute) disease. US is not normally per-
formed in routine assessment of myositis due to poor response from inflammation
(oedema). Although the system successfully differentiates betweens healthy and
diseased individuals, it is not clear if the system can successfully differentiate the
degree of disease state.
3.8 Quantification of meniscus tears
Ramakrishna et al. [61] developed an algorithm to detect tears in the meniscus.
The meniscus is a supporting structure located in the knee joint and is different
from cartilage and bone. The meniscus may become broken when subjected to
rotational forces.
Although the problem domain is different, Ramakrishna et al. presented a
similar situation in that a diagnosis was previously made by a radiologist through
visual inspection of MR scans. An objective measure of the severity of the breakage
was sought. Due to the variation in signal intensity that is expected from MR scans
(e.g. between different hospitals and scanners), the authors designed an algorithm
with an adaptive threshold which could be calculated automatically for each case.
In a preprocessing stage, the ROI is first selected by choosing a region with
the lowest mean intensity as calculated using all the slices in an image cube [61,
p. 1311]. A “mean image” is described by
M(i, j) = mean
{
Ik(i, j)|Ik ∈ Sinitial
}
(3.5)
where M is the mean image of all sagittal slices Ik in the set Sinitial. Matrix M
is then split horizontally into submatrices denoted Wn. Each Wn is 16 rows high.
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The average intensity for each Wn is found and the minimum is selected; this
submatrix is denoted n∗. The centre row of n∗ is the centre of the ROI denoted
IROIk which has size 180×100. In a process that is not detailed here, the set Sfinal
contains only some slices of Sinitial.
After the preprocessing stage an adaptive threshold is calculated in order to
binarise the images in IROIk . The threshold is 0.2µ, where
µ = mean
{
IROIk |Ik ∈ Sfinal
}
. (3.6)
The binarised images have a number of segments, and these are filtered based
on shape and size parameters (e.g. length-to-width ratio, area). This process is
repeated on the set of slices with an increased threshold, in steps of 0.05µ up to
0.8µ. The threshold that resulted in the maximum number of filtered segments
is selected. Let τ ∗ be this threshold. The filtered segments are used to extract
objects from the original image.
The authors define two measures: breakability and degenerability. Breakbility
is measured by the maximum number of segments that result when considering
a set of five thresholds 0.7τ ∗, 0.6τ ∗, . . . , 0.3τ ∗ applied to the extracted objects. A
score is assigned to each of the five thresholds. Degenerability uses the same five
thresholds on the extracted objects to measure the rate with which the area of the
resulting segments decrease.
The authors found that tears running through consecutive slices have a higher
chance of being true tears, and so continuity scores are calculated
αˆk = 0.25αk−1 + 0.5αk + 0.25αk+1, (3.7)
βˆk = 0.25βk−1 + 0.5βk + 0.25βk+1, (3.8)
where αk is breakability for slice k, and βk is degenerability for slice k. αˆk and βˆk
are then combined into a final score.
The sensitivity and specificity of the algorithm was found to be 83.87% and
75.19% respectively. An experienced radiologist attained sensitivity of 77.41% and
specificity of 81.39%. I.e. the algorithm was slightly better at diagnosing positive
cases as positive, but worse at identifying negative cases as negative, compared to
a radiologist.
Ko¨se, Genc¸aliog˘lu and S¸evik [47] also present a different method for the auto-
matic diagnosis of meniscus tears. The authors present several different techniques
to locate the meniscus ROI in MR images taken in the sagittal plane. The tech-
niques were used on a collection of approximately 500 archived images from 30
patients.
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The authors used vertical and horizontal histograms to utilise the knee morpho-
logy, but note that the histograms should be smoothed, normalised, and scaled to
account for differences in presentation (e.g. the angle between the tibia and femur).
If the vertical and horizontal histograms do not match reference histograms then
the original input image may be rotated and the histograms recalculated. Then
the extreme values in the histograms are used to find the meniscus ROI.
A second histogram based method uses an edge-filter on the input image first.
The authors used five different edge-filters (Sobel, Prewitt, Roberts, Robinson,
and Frei-Chen). The vertical and horizontal histograms are then only computed
for pixels above a threshold and the resulting histograms are normalised. The
extreme values in the normalised histogram are then used to find the meniscus
ROI. Out of the five filters, results showed Sobel, Prewitt, and Frei-Chen gave the
best horizontal localisation.
A statistical segmentation technique was also evaluated. Characteristic images
of the bone region are used to find statistical properties of the bone texture. In
a training step, the bone region from an input image is segmented and a small
seed image is randomly selected out of the bone region. Many small images of
the same size are then randomly selected from the bone region and the average
error threshold is computed against the seed image. This process is repeated
many times and the characteristic images with the minimum average error are
selected and the statistical properties calculated on these images. Segmentation is
performed by taking a small sample image around the centre of a pixel in the image
and calculating the statistical properties. The difference is calculated against the
characteristic images’ properties. When the difference is under some threshold,
the centre pixel is considered bone, otherwise it is considered non-bone. This is
done for all pixels in the image. The resulting segmentation is enlarged using an
adaptive region growing technique. Finally, the vertical and horizontal histograms
of the segmented bone region are computed and used to find the meniscus ROI.
The authors state that the most invariant morphology for locating the men-
iscal region is the bones, although the statistical bone segmentation technique
resulted in only 82.0% of meniscal regions accurately located when using both top
(femur) and bottom (tibia) bones. When using only the femur bone the statist-
ical segmentation technique resulted in 94.0% of meniscal regions accurately loc-
ated. The histogram based method which had two maximums as reference points
achieved 99.0% accuracy in localising the ROI vertically, but performed badly
overall (38%) due to horizontal inaccuracy. The normalised histogram method
using edge-filtered images attained a horizontal accuracy of up to 98.0%.
The meniscus ROI is binarised using Otsu’s method and the meniscus is identi-
fied using triangle templates of various sizes. The search region is restricted, based
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on statistical information of the most likely locations. Tears are identified as low
intensity pixels surrounded by high intensity pixels and the ratio of meniscus to
tears is calculated using real areas (as computed using the metadata recorded in
the DICOM file). If this is above some threshold value then the diagnosis is posit-
ive. Results showed the algorithm successfully diagnosed 88.3% of 30 knees with
tears and 95.7% of 70 knees without tears.
In summary, Ko¨se, Genc¸aliog˘lu and S¸evik [47] presented several different meth-
ods in attempt to identify the ROI. Using an edge filter was successful in identi-
fying the meniscus due to the greater number of edges in that area. Vertical
and horizontal histograms can also be used to locate objects. The meniscus was
binarised using an automatic technique called Otsu’s method, which assumes the
image has “background” and “foreground” pixels, whereas Ramakrishna et al. [61]
used a simple adaptive threshold technique. In either case, thresholding worked
well because that part of the process must detect tears, which are visible as lines
running through the meniscus and therefore naturally lends itself to segmentation.
Ramakrishna et al. [61] utilised the information from consecutive slices whereas
Ko¨se, Genc¸aliog˘lu and S¸evik [47] did not. Examining consecutive slices meant
the algorithm gave higher scores when the presentation was more obvious. Ko¨se,
Genc¸aliog˘lu and S¸evik [47] only gave a binary diagnostic decision, whereas Ra-
makrishna et al. [61] also quantified the extent of the tears.
3.9 Multiple sclerosis lesion segmentation using
joint histogram
Zeng and Zwiggelaar [75] propose the use of T1 and T2 sequences to build a joint
histogram and present an automatic method to segment MS lesions in the brain.
They explain that the brain is largely made up of grey matter and white matter
tissues and that the joint histogram therefore has an expected appearance, with
the different tissues separated. They show that this cannot be done with standard
histograms for T1 and T2 separately.
The cluster centres for grey matter and white matter tissues are calculated
and a rectangular region in the joint histogram is computed using the cluster
coordinates. The presentation of MS lesions in MR images is hypointense T1
signal and hyperintense T2 signal (both with respect to normal white matter),
and therefore the rectangular region is assumed to contain the MS lesion.
The cluster centres are calculated using a class-adaptive Gaussian Markov
random field model with 5 initial classes to segment the joint histogram, and the
number of classes is increased until the white matter and grey matter regions are
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distinct. Once this has been done for the middle slices in the set, the cluster centres
are propagated to neighbouring slices by using a small circular region around the
centres which is used as an initial estimate on the neighbouring slice.
Unwanted data in the joint histogram are removed by creating a mask of the
most dense areas (using fuzzy C-means with 2 clusters) and then using morpho-
logical operators to refine it. The lesion pixels are selected from the original T1
and T2 images using the histogram mask and the rectangle region to pick out
the intensity values of interest. After the regions have been selected from all the
slices, regions which are not in roughly the same location in neighbouring slices
are removed to reduce false positives.
3.10 Multiscale vessel enhancement filtering
Frangi et al. [21] describe the idea of filtering an image or volume for shapes that
are tubular at a certain scale s. Tubular objects are assumed to be blood vessels.
They show the technique on examples from magnetic resonance angiography (MR
for blood vessels) and X-ray.
Frangi et al. start by introducing the Taylor expansion for the input image L
at a point xo,
L(xo + δxo, s) ≈ L(xo, s) + δxTo∇o,s + δxToHo,sδxo (3.9)
where s is the scale parameter, ∇o,s is the gradient (first-order) of image L at xo,
and Ho,s is the Hessian matrix (second-order) of image L at xo. The Hessian is a
square matrix which contains the second-order partial derivatives of the function.
They state that in this framework differentiation is the convolution of the input
image with the derivative of Gaussian and give the equation
∂
∂x
L(x, s) = sγL(x) ∗ ∂
∂x
G(x, s), (3.10)
where G(x, s) is a D-dimensional Gaussian such that,
G(x, s) =
1
(2pis2)
D
2
e−
‖x‖2
2s2 . (3.11)
Although not explained in the paper, it is important to realise that the expres-
sion (L ∗G)′ can be rewritten L ∗ (G′), meaning that the differentiation of image
L can be done by differentiating the function G and then convolving with L. In
Equation 3.9 the third term describes local curvature by using the Hessian matrix,
and this can be calculated by pre-computing the second-order partial derivatives
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of G for a given scale s and then convolve with L.
Frangi et al. stated that the second-order Gaussian is particularly suitable for
vessel detection since the function is similar to the expected change in intensities
presented by a blood vessel.
That is, a blood vessel is essentially a tube of a certain diameter filled with
moving fluid (with the central fluid moving moderately quicker than fluid towards
the tube walls) and the second-order Gaussian has a shape well suited for this
structure.
Information on the local second-order structure of the image is extracted using
eigenvalue analysis of the Hessian matrix. The eigenvector and eigenvalue give the
principal direction of curvature in the local neighbourhood. For a volume they
order the eigenvalues such that |λ1| ≤|λ2| ≤|λ3| and suggest that
|λ1| ≈ 0 (3.12)
|λ1| |λ2| (3.13)
|λ2| ≈|λ3| (3.14)
so that a blood vessel may be found. The polarity of any λk indicates whether it
is a bright object on a dark background or vice versa.
Frangi et al. suggest a vesselness measure for two-dimensional images,
Vo(s) =

0 if |λ2| > 0,1− exp(− S2
2c2
) exp(−RB2
2β2
)
otherwise,
(3.15)
where
RB =
λ1
λ2
, S =
√∑
j≤D
λ2j ,
and β varies the input from “blobness” measure RB, and c varies the input from
“second order structureness” measure S. The condition of Equation 3.15 may
be reversed depending on the modality and the appearance of the vessel (bright
on dark or vice versa). In order to assess vessels at different scales Frangi et al.
suggest calculating Vo(s) for a range of s values and selecting the maximum.
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3.11 Conclusion
In this chapter, previous work from similar and related domains has been reviewed.
Some very important insights have been gained and this knowledge will be lever-
aged in Chapter 4 where the MRI scans are carefully prepared before disease
analysis.
Chapter 4
Pre-Processing
Now that the background has been introduced and literature from similar domains
explored, it is possible to appreciate the inherent requirement for pre-processing
MRI data. The processes described in this chapter are fundamentally important
in preparing the data in order that quantitative measures of inflammatory muscle
disease may then be constructed (Chapter 5).
4.1 Overview
Figure 4.1 shows an outline of the steps required to process the scans. A summary
of the steps will be detailed here, and the subsequent sections in this chapter go
into further detail. In Step 1-A, a contiguous set of 6 slice pairs are selected from
the scanner output and are then loaded from DICOM format in Step 1-B. The T1
and STIR images are aligned in Step 1-C and then scaled to a common pixel size
in Step 1-D. An initial ROI is computed in Step 1-E. In Step 1-F the slice pair
is corrected for non-uniformity effects. Fat and muscle tissue centres are found
in Step 1-G. A refined ROI is computed in Step 1-H to reduce partial volume
effects seen in the joint intensity space. Step 1-I is a specially developed tool
to remove the femur (bone and bone marrow) using a semi-automatic process.
In Step 1-J the largest arteries and veins in the leg are masked out. Step 1-K
performs intensity standardisation suitable for the pathology under consideration.
In Step 1-L the intensity space is segmented to get muscle and fat regions.
These steps are essential in order that the data is normalised to a standard
frame of reference for the problem domain, and that all data which is not useful
in diagnosis is discarded before further analysis (to help prevent any unexpected
bias).
37
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(Step 1-A) Slice pair selection
(Step 1-B) Load from DICOM
(Step 1-C) Registration of slice pairs
(Step 1-D) Geometric scaling
(Step 1-E) Initial region of interest
(Step 1-F) Bias correction
(Step 1-G) Localisation of tissue centres
(Step 1-H) Region of interest refinement
(Step 1-I) Specialised femur removal tool
(Step 1-J) Femoral vessels removal
(Step 1-K) Intensity scaling
(Step 1-L) Static segmentation
Pre-processing
Figure 4.1: Process diagram showing the steps in pre-processing the data.
4.2 Notation
Some notation is introduced here, which is used in subsequent sections. The
notation is the same which appears in [37].
An image may be thought of as a function f : X→ R+, where
X = Z+m × Z+n =
{
(x1, x2) ∈ Z2 : 1 ≤ x1 ≤ m, 1 ≤ x2 ≤ n
}
, (4.1)
which forms a rectangular lattice [62], where m is the image height, n is the image
width, (x1, x2) is the coordinate, and Z is the set of integers. The same image
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may be represented equivalently by the structure
f = {(x, f(x)) : x ∈ X}, (4.2)
where x is the pixel location. For convenience the two source types, T1 and STIR,
will be represented by t and s, respectively, for the remaining chapters.
A bivariate histogram (or joint histogram) may be computed in the following
way. The intensities of the input images t and s must be discretised for pixels in
a Region Of Interest (ROI) e.g. for some mask g(x) = 1. The discretised images
will be denoted tˆ and sˆ, respectively, assumed to have 128 intensities, although
other ranges may also be used.
For each entry (u, v) in a bivariate histogram, a subset ξ(u, v) ⊂ X is defined
by
ξ(u, v) = {x : sˆ(x) = u ∧ tˆ(x) = v} (4.3)
where 0 ≤ u ≤ 1 and 0 ≤ v ≤ 1. The bivariate histogram is then
h = {((u, v), 1
N
|ξ(u, v)|) : (u, v) ∈ [0, 1]× [0, 1]}, (4.4)
where N = |{x : g(x) = 1, x ∈ X}|, h is of size 128×128, and |s| is used to
denote the number of elements in a set s. In words, the bivariate histogram is a
normalised tally of the occurrences of joint intensity (STIR pixel, T1 pixel) for
all pixels in the ROI. In the instance where a ROI has not been defined then it
includes all locations x.
4.3 Slice pair selection (Step 1-A)
For each sequence, the MRI machine writes a set of DICOM files into a single
directory. Any number of directories may be available depending on what invest-
igations were performed. The correct body region must be identified. In general,
it is necessary to check the sequence parameters from the DICOM meta-data to
ensure acquisition parameters are correct. Table 4.1 shows some example data.
Slice Location is important to check between sequences to ensure that slice pairs
refer to the same physical slice plane. Although some data is recorded automat-
ically by the MRI machine, other data is entered manually and occasionally this
is erroneous.
A set of 6 contiguous slice pairs are selected from T1 and STIR directories.
Slices are selected below symphysis pubis and the gluteus maximus muscle is
excluded. Any gross imaging artefacts are avoided, if present.
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DICOM Key Name Example value
0008-103E Series Description Axial T1 Thigh
0018-0050 Slice Thickness 8 mm
0018-0087 Magnetic Field Strength 1.5 T
0020-1041 Slice Location -28.35 mm
0028-0030 Pixel Spacing 0.88 mm
Table 4.1: Example DICOM keys checked before loading.
The selection of the number of slice pairs to use per case was determined by
a number of factors. Utilisation of all available scans (including historical scans)
restricted the number of usable contiguous slice pairs, due to variation in the exact
body location which was imaged. However, due to the “patchy” nature of the
disease, adequate coverage of the leg muscle was assumed to be important. Since
the standard protocol dictates that slices are acquired at 10 mm intervals, then 6
contiguous slices surveys a region of leg 6 cm in length. A greater number of slice
pairs per case would be preferred, however the overall number of scans meeting
this requirement would be greatly reduced. Therefore 6 slices was selected as a
sensible minimum based on the consideration of the above factors.
It was assumed statistically superior to use the largest muscles (indeed, this is
why the protocol is for the thighs) and therefore slices towards the upper thigh
were selected in preference to those closer to the knee. Note that this process need
only be performed once per case.
4.4 Loading scans (Step 1-B)
DICOM files were loaded into memory. Images were normalised to [0,1] range
(per slice). A table-like data structure was used such that all data pertaining to
a “set” could be looked up: Table 4.2 shows an example.
Column name Type Example
Set Integer 2
Slice Integer 5
Type String ‘T1’, ‘MASK’
Control Boolean True/False
Diagnosis String ‘positive’
File String ‘IM6’
Image Object data structure
Table 4.2: Example data in a row of the lookup table. The Image
object also contains important data from the DICOM data.
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4.5 Slice pair registration (Step 1-C)
Registration is a process of finding a transformation that maps from one image
space to another such that the two images may be superimposed and thus the
corresponding objects in the scene will be in alignment. In general, registration
is required as images may have been taken at different points in time (multitem-
poral), with different sensors or machines (multimodal), with differing sequence
settings (multispectral), or from different viewpoints (multiview). There are many
clinical and research applications for registration [51; 43]. Note that there is no
clear distinction between multimodal and multispectral terms.
One image is said to be the reference image, which is static, while the other
image is called the sensed, target, or moving image, which is transformed or mapped
to align with the reference image [43, p. 236].
Registration can be split into four distinct categories based on the nature of the
transformation used. These are rigid, affine, projective, and elastic [51, p. 8]. The
coordinate transformation is considered rigid when only translation and rotation
are considered and can be defined in 2D by
x′ = Rx+ t (4.5)
where t = (a5, a6)
T is a shift vector for translation and R is the rotation matrix
R =
[
cos θ − sin θ
sin θ cos θ
]
. (4.6)
When parallel lines are mapped onto parallel lines the transformation is named as
affine. In 2D it is defined by
x′ = Ax+ t (4.7)
where
A =
[
a1 a2
a3 a4
]
(4.8)
is the affine matrix [20, p. 1381]. The affine matrix is a composition of rotation,
scale, and shear transforms: A = RSE [23, p. 346]. Projective transformations
map lines on to lines, although parallel lines may not remain parallel after it is
applied. It can be defined in 2D by
x′ = Bx (4.9)
where B is an arbitrary 3×3 homogeneous matrix [51, p. 8]. An elastic transform-
ation (also called a warping, mesh, deformable or curved transformation) may
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be described by mapping lines onto curves. It might be represented by a local
displacement field such as x′ = x+ t(x).
Registration is used to ensure that the T1 and STIR images are in alignment.
Since the time taken between acquisitions of the sequences is minimal, it was
assumed that a constraint of rigid registration would be sufficient. As already
discussed in section 3.4, it is clear that some registration may be required even
with a strict acquisition protocol.
The affine transformation may be limited to scaling and translation by adjust-
ing Equation 4.7 such that
x′ =
[
s1 0
0 s2
]
x+ t. (4.10)
The search space that must be considered is [s1, s2, t1, t2], a brute-force search of
which is infeasible, partly due to the number of operations required for a single
registration of two input images of reasonable size. The search space can be
viewed as an optimisation problem where the registration measure must be either
minimised or maximised. An optimiser may use a gradient descent method [23] to
estimate s1 and s2 parameters, although the application of a scaling transform will
have an effect on the translation parameters t1 and t2 [74]. The scaling transform
should be applied to the center of the objects in the image, as described by
x′ =
[
s1 0
0 s2
]
(x− C) + C + t (4.11)
where C is the center [74, p. 257].
With experience, the required adjustment to the moving image were small
for all parameters [s1, s2, t1, t2]. Registrations for the training database were ex-
amined. The range for scale parameters [s1, s2] for the training database were
found to be small in the general case, but on occasion was much larger than
necessary, causing gross misalignment.
The registration was further constrained to translation-only registration for
the following reasons:
• A widened search space with parameters [s1, s2] (as compared to [t1, t2] only)
combined with poor SNR of STIR input occasionally resulted in gross mis-
alignment.
• High quality fat suppression achieved in STIR sequences could result in very
dark or no signal from fat tissue, which may have contributed to inadequate
alignment.
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• From experience, the range of (visual) misalignment was small (less than 2
pixels in either dimension).
• In examining a great number of registrations (by fusion of the two images)
translation-only alignment was seen to be effective.
Registration based on translation only has an advantage of being computa-
tionally simple and is often quick. Note that this could only be achieved due to
the specific protocol used in this problem domain, with identical geometry for a
slice pair.
4.6 Geometric scaling (Step 1-D)
Utilising the DICOM meta-data, all images were scaled to a common pixel dimen-
sion. The scale factor was chosen to target 0.74mm/pixel, chosen such that all
images in the database were magnified.
4.7 Region of interest construction (Step 1-E)
Without any Region Of Interest (ROI) the joint histogram generated for a slice
pair will result in one very dense peak representing very low T1 and STIR intensity,
resulting from the large number of dark pixels from the background region. For an
example, see (a) in Figure 2.2 (page 8). In this step the ROI is defined to remove
the large background region. Later in pre-processing (Step 1-H and Step 1-I) the
ROI is refined.
A simple masking technique has been designed to select a region of a few pixels
around the legs, applied to each slice pair. The T1 image is used to create the
mask, but may be applied to both images in the pair, as they have been registered.
As previously discussed, the STIR image is often noisy, thus using the T1 image
was considered advantageous.
Thresholding the T1 image, followed by erosion, creates the first mask
m1 =
{
(x, c(x)) : c(x) = 1 if t(x) ≤ 0.05, otherwise c(x) = 0}	D(3) (4.12)
where D(r) is a disk-shaped structuring element with radius r, and 	 is mor-
phological erosion. m1 is now assumed to cover the majority of the background
region, which contains small variations in intensity due to noise. A local standard
deviation filter is used to measure variations throughout,
j(x) = stdev{t(x) : x ∈Mx} (4.13)
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where Mx is the 5×5 neighbourhood of X centred at x ∈ X. The maximum
standard deviation of interest is then
ρ = max{j(x)m1(x) : x ∈ X}. (4.14)
ρ is the selected threshold for mask
m2 =
{
(x, c(x)) : c(x) = 1 if j(x) > ρ, otherwise c(x) = 0
}
. (4.15)
The outermost region where m2 is 0 defines the background region. The standard
binary reconstruction technique is used with f0 as the initial blank image with seed
f0((1, 1)) = 1, assumed to be background. Defining ⊕ as morphological dilation
then
fk =
(
fk−1 ⊕D(1)
) ∩mc2 for k = 1, 2, . . . (4.16)
until fk = fk−1, and note that mc2 denotes the complement. Using ff as the final
case then the ROI is
g = f cf . (4.17)
The above process is shown in Figure 4.2.
Although m1 is based on a simple threshold of the raw T1 image, it is reas-
onable to assume that the background is less than 1
20
of the brightest pixel before
intensity standardisation. This process was found to be sufficient for all cases in
the training database.
4.8 Bias correction (Step 1-F)
The N4ITK method [67] was selected as the inhomogeneity correction method (see
related discussed in section 3.4) for the following reasons:
• The previous version (N3 [65]) has been used on large MRI databases, e.g.
ADNI.
• The updated method (N4ITK) is an improvement over N3.
Other methods were briefly investigated, but it was common to find a reduction
in pathologically useful information (e.g. severely reduced intensity spread over
tissue centres) where the correction method had worked “too well”. (Note that
subsection 3.4.2 covered the possibility of “overstandardizing” [63, p. 7], although
that discussion was not related to inhomogeneity correction.)
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T1 input with g outline
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j showing m1 only
ρ
Figure 4.2: Overview of the process for computing the ROI.
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4.9 Localisation of tissue centres (Step 1-G)
The bivariate histogram must be generated from the registered and bias-corrected
inputs, using the ROI from Step 1-E. The computation for generating the bivariate
histogram was described above.
Popular clustering algorithms were investigated, including k-means, DBSCAN,
and affinity propagation, however these algorithms produced results that were
often unsatisfactory when considering the whole training database. For instance,
k-means did not always locate cluster centres satisfactorily, and largely relied on
the starting seed locations.
Therefore a technique was developed that would be robust against changes in
the bivariate histogram space: some changes are expected due to variation in the
quantity of different tissues and their intensity, however some basic rules may be
defined on the basis that any bivariate histogram that violated the rules would
be most likely the result of improper sequence settings, severe MR artefact, or
misregistration.
It is expected that:
• Two main tissue clusters exist in the intensity space. The femur bone and
bone marrow is removed in a later step, but this region should not be a
significant fraction of the overall leg, and therefore its contribution is not
expected to distort the overall shape of the bivariate histogram. In practice,
this is always true, even for slice pairs acquired towards the knee, where
muscle may be relatively sparse.
• STIR signal from muscle inflammation (oedema) has the same approximate
T1 intensity as healthy muscle.
• T1 signal from muscle and fat is sufficiently distinct (e.g. more than 10% of
the total T1 intensity range).
Given the above constraints are met, then the following method is seen to be
robust. Algorithm 4.1 is a generalised method for finding an approximate peak
location in a bivariate histogram over a defined ROI (in intensity space) given
template parameters.
The muscle and fat centres were found using different template parameters
but using the same method (Algorithm 4.1). With the bivariate histogram H
computed (dimensions 128 × 128), then the templates defined in Table 4.3 were
used. (fs, ft) is the fat centre, and (ms,mt) is the muscle centre. N1 and N2 are
the number of ranked indexes to average in each dimension.
The results were manually checked for every image-pair in the training data-
base, judged by visual inspection. Note that the parameter N2 is greater for the
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Algorithm 4.1: Find approximate cluster centre location
Data: Joint histogram H of size y × x, search space (y1, y2),(x1, x2), and
N1, N2.
Result: Approximate cluster centre (Ly, Lx)
1 Ri =
∑
x∈[x1,x2] Hi,x
2 Ci =
∑
y∈[y1,y2] Hy,i
3 J ← list of pairs (i, Ri) ranked in descending order of Ri
4 K ← list of pairs (i, Ci) ranked in descending order of Ci
5 Ly ← mean of indexes i in the top N1 pairs of J
6 Lx ← mean of indexes i in the top N2 pairs of K
7 Ly ← Ly/y
8 Lx ← Lx/x
9 return (Ly, Lx)
Output Template parameters:
(y1, y2, x1, x2, N1, N2)
Muscle centre (ms,mt)← Algorithm 4.1(8, 80, 7, 60, 6, 6)
Fat centre (fs, ft)← Algorithm 4.1(1, 64, 64, 128, 6, 10)
Table 4.3: Template parameters for fat and muscle clusters.
fat cluster than the muscle cluster, owing to its elongated spread in the T1 dimen-
sion. Using the average of 6 intensity indexes was found to be sufficient for the
other template parameters, for all cases investigated. The averaging process in Al-
gorithm 4.1 means that the algorithm was not overtly misled by a local maximum,
distant from the main cluster. The use of column and row sums was inspired by
the work of Ko¨se, Genc¸aliog˘lu and S¸evik [47] (see section 3.8).
4.10 Region of interest refinement (Step 1-H)
Algorithm 4.2 takes the first ROI, as described in section 4.7 (Step 1-E), and
iteratively “shrinks” it until all pixels on the edge of the mask are above a heuristic
value based on the T1 fat centre ft (see Table 4.3). Essentially the mask is
drawn slightly within the fat layer of the legs, thereby removing partial volume
effects, resulting from the background region. An example ROI and the effect of
refinement is shown in Figure 4.3.
4.11 Femur removal tool (Step 1-I)
The femur is removed from the slice pairs because the data is assumed to carry
no diagnostic value (for IIM). In removing the data contributed by the femur, any
possible bias presented is eliminated from further analysis. The reasoning here is
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Algorithm 4.2: Refine region of interest
Data: T1 image T , region M , cluster value ft
Result: Region L
1 L←M
2 R← T < 0.3ft
3 repeat
4 C ← L ∩ (L	D(1))
5 X ← {x : C(x) = 1 ∧R(x) = 1}
6 L(X)← 0
7 until X = ∅
8 return L
Algorithm 4.3: Weak segmentation process.
Data: Image T , seed point s, percentile rank p.
Result: Femur mask M
1 ηsample = { intensities of pixels within a radius of 22.2mm from seed s }.
2 Find c such that
|{i : i ∈ ηsample, i ≤ c}|
|ηsample| ≈
p
100
.
3 N ← T > c.
4 N ← N with binary reconstruction from seed s.
5 N ← N ⊕D(3), where D(r) is a disk shaped structuring element with
radius r.
6 N2 ← N with binary reconstruction from point (1, 1), assumed to be
background.
7 M ← N ∨ ¬N2.
8 return M
simply that by removing data not immediately useful for diagnosis for IIM, the
possibility of confounding issues is avoided.
Previously, the femur had been semi-manually segmented for each new scan
entered in the training database. These masks were carefully checked to cover
the correct region. However, this semi-manual approach was extremely laborious.
The original regions will be denoted ωi, where i = 1, . . . , N .
In general, it was found that thresholding the T1 slice adequately differenti-
ated the femur bone from the surrounding tissues. Given a seed coordinate from
the operator, the femur and surrounding region could be extracted. It was also
observed that segmentations from adjacent slices were often similar. However,
the threshold value was found to be sensitive, as was the exact seed coordinate.
Therefore, it was thought that this method was a weak segmentation process which
could be utilised successfully en masse.
Algorithm 4.3 returns a candidate region which is assumed to cover the femur
and ∼2.22mm beyond it. The concept is to then trial many points around a seed
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Figure 4.3: An example showing the effect on the joint histogram of applying
a ROI. (a) is a composite image showing the T1 and STIR input images. The
outer contour shows the first ROI as computed in Step 1-E and the inner contour
shows the subsequently refined ROI from Step 1-H. (b) shows the resulting joint
histogram when no mask is applied, where the signal from background pixels (low
signal on both T1 and STIR, as can be seen in the top-left corner) overwhelms the
signal from the fat and muscle. (c) shows the resulting histogram with the first
ROI applied (Step 1-E). (d) shows the resulting joint histogram with the refined
ROI (Step 1-H). Careful comparison of (c) and (d), reveals a reduction in the
number of pixels from the fat tissue with hypointense T1, essentially making the
definition between fat and muscle clusters more apparent.
location using this weak segmentation process and then rank the candidate regions
in a scoring process.
The original masks ωi were first analysed to better understand the problem
domain. The femur centroids and pixel area were computed and statistics were
calculated (Table 4.4). Clearly, the femur centroid does not often move more than 3
pixels in any direction between slices. Therefore, it is assumed that a suitable seed
point (located on the femur bone) will also tend to be within a certain boundary
around the previous seed point (that is, from the prior slice). Anatomically, this
is intuitive since the femur bone does not have kinks and slices are 10mm apart.
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LCdiff RCdiff BCdiff Cardinality
Mean 2.483 2.274 2.378 1483
Median 2.221 2.058 2.121 1479
Min 0.209 0.120 0.120 936
Max 6.144 5.507 6.144 2149
Table 4.4: Analysis of femur centroids for the training database. LCdiff
denotes the Cartesian distance between adjacent slices of the left femur
centroid. Similarly, RCdiff refers to the right femur centroid. BCdiff
refers to left and right sets combined. Cardinality is the number of
pixels covered (left and right sets).
Algorithm 4.4 makes use of this prior knowledge. An initial seed point s is used
for segmentation of the first slice T1. In instances where the bone is thin, the initial
seed point may not be viable (line 2) and another (dark) pixel with proximity is
selected. From line 8, the method predicts a region of trial seed points for the
current slice based on the prior (successful) seed point. The region defined by
Z1 (line 9) is trialled first (a heuristic based on the results of Table 4.4), which
allows the algorithm to finish early for “easy” problems. Region Z2 is a large
fall-back region, used when the number of suitable candidates from Z1 is low.
Given a candidate seed point q, metrics are calculated (line 15 to line 18) on
the segmentation C. Clearly bad regions are discarded (line 20), again based on
the results of Table 4.4. On line 25, the remaining candidate regions are ranked
and the top-scoring region is selected. Figure 4.4 shows two steps in a femur
segmentation.
Parameter p was chosen to be 23 and worked in almost all cases. However, in
a couple of cases this value was insufficient and p = 17 was elected instead. It was
noticed that MR scans acquired prior to 2005 were particularly likely to require
this adjustment.
With this approach, the weak segmentation process has been made robust to
within the expected limits of the training database. Given a larger database, this
method may be extended to satisfy further variations in presentation. For instance,
line 12 may be expanded to accommodate a larger possible search space, as defined
by Z1 and Z2 (line 9, line 10). Indeed, the method may be further tailored to
specific circumstances. As an example, it could be assumed that any trial seed
point with an intensity greater than 0.5 will result in a correct segmentation,
and therefore Z1 and Z2 may be initially vetted. Further technical optimisations
appropriate for the hardware are surely possible. For instance, harnessing graphics
processing hardware would allow images to be thresholded in a batch. The overall
method is easy to understand and may be augmented for individual requirements.
To evaluate the performance of this tool, the computed regions were compared
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Algorithm 4.4: Segment one femur for a whole set.
Data: T1 slices Ti, i = 1, . . . , N , seed point s, percentile rank p.
Result: Femur masks Ji
1 J1 ← Algorithm 4.3(T1, s, p)
2 if
∑
J1 = 0 then
3 w ← {s+ x : ||s+ x||2 ≤ 2 ∧ x > 0} // chessboard distance
4 s← pixel w with lowest intensity.
5 J1 ← Algorithm 4.3(T1, s, p)
6 if
∑
J1 = 0 then
7 return ∅ // assume bad seed, or try new p
8 for k ← 2 to N do
9 Z1 ← {s+ x : ||s+ x||2 ≤ 3} // common trial region
10 Z2 ← {s+ x : ||s+ x||2 ≤ 7 ∧ s+ x /∈ Z1} // uncommon trial region
11 Initialise Q as an empty list of candidates.
12 for m← 1 to 2 do
13 foreach point q in Zm do
14 C ← Algorithm 4.3(Tk, q, p)
15 n←∑C
16 d← 2|C∩Jk−1||C|+|Jk−1| // Dice coefficient
17 g1 ← 110 ||centroid(C)− centroid(Jk−1)||
18 g2 ← ||centroid(C)− q||
19 Append to Q the candidate parameters {n, d, g1, g2}.
20 Q← Q satisfying: 800 < n < 2300 ∧ g1 ≤ 1.
21 if |Q| > 2 then
22 break
23 if |Q| = ∅ then
24 return ∅ // try new p
25 Rank Q by score d+ g1, then g2 (descending,ascending).
26 Pick the top candidate, denoted q′.
27 Jk ← Algorithm 4.3(Tk, q′, p).
28 s← q′.
29 return Ji
with the original regions ωi, which are considered a suitable proxy for ground
truth. The new computed masks will be denoted ρi, where i = 1, . . . , N , and
N = 186. The test calculated the Dice [13] and Jaccard [36] scores for all T1 slices
in the training database. The results are shown in Table 4.5. Note that from
visual inspection, it was clear that the new method was just as appropriate as
the original masks, given that there is some leeway on exactly what region should
be considered for removal (see Figure 4.5). Consider that the main goal of the
segmentation is to remove possibly confounding data; not to delineate the exact
femur shape.
It is possible to use other methods for the task of bone segmentation. Level
set methods, for instance [76], have been applied previously to medical image
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Figure 4.4: The second (a) and third (b) steps from a femur segmentation using
Algorithm 4.4. Note that (a) is a magnification of Figure 4.5 (a). In both cases
the smaller set of Z1 trial points can be seen as +. The circled point indicates
the new chosen seed point. In (b) the × indicates the previous seed location: the
circled point from (a).
a b c
d e f
Figure 4.5: Comparison of old and new femur segmentation methods. (a)-(c) are
the original segmentations from ωi, and (d)-(f) are the new segmentation ρ. Note
that (c) was chosen for its difficulty in that the femur bone is both large and thin.
Dice Jaccard
Mean 0.95 0.90
Median 0.95 0.90
Min 0.88 0.78
Max 0.99 0.98
Table 4.5: Scores to compare the difference
between ground truth (proxy) ω and the proposed
method yielding ρ.
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segmentation problems. However, the above proposed method is straightforward,
easy to implement, suitable for parallelism, produces sufficiently accurate results,
and may be easily augmented.
4.12 Vessel removal (Step 1-J)
Automatic methods for vessel segmentation were briefly investigated (e.g. [21; 40]),
however it was found that the presentation of blood vessels in the STIR sequences
were varied and subject to gross imaging artefacts caused by the movement of
blood. In some cases, the similarity in appearance between blood vessels and
oedema was a major confounding issue.
In a manual process, the two great femoral vessels are masked with the applic-
ation of a 14.8mm diameter disc placed over the vessel. Anatomically, the vessels
are not expected to be bigger than this size.
It is clear this step could benefit from automation, however this aspect is left
as a possibility for future improvement.
4.13 Linear intensity scaling (Step 1-K)
By examining many different joint histograms from the training database, it was
possible to see that they all had a common theme but with some smaller changes,
for instance the shape of the muscle and fat clusters (see Figure 4.6).
a b
c d
Figure 4.6: The appearance of joint histograms can vary. (a), (b), and (d) are
control cases. (c) has confirmed disease. Cluster centres have been marked.
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As an initial step using image manipulation software, it was possible to manu-
ally compare joint histograms between two patients by scaling and translating one
joint histogram until it overlapped with the other. This would allow to compare
and contrast between scans and patients. The hypothesis was that, by examining
enough cases, a general trend could be found to show the disease state in the joint
histogram space.
To this end, an automatic method was sought to bring all scans in the database
into a common space. This was achieved by using the muscle and fat centres (de-
tailed in section 4.9) and linearly scaling them to pre-defined intensities. Defining
T1 and STIR images such that T = {ti : i = 1, . . . , n} and S = {si : i = 1, . . . , n},
respectively, where n is the number of pixels, then their intensities were trans-
formed using
λt =
αt
ft −mt λs =
αs
ms − fs (4.18)
κt = βt − λtft κs = βs − λsms (4.19)
t′i = (tiλt + κt) s
′
i = (siλs + κs) (4.20)
t′′i = t
′
i clamped to [0, 1] s
′′
i = s
′
i clamped to [0, 1] (4.21)
where subscript s refers to STIR, subscript t refers to T1, α is the desired space
between centres, β is the desired transformed centre, and f and m are the fat and
muscle centres, respectively (section 4.9).
Note that t′i and s
′
i are referred to as the unclamped intensities, which may fall
outside the range [0, 1]. Generation of the joint histogram using t′′i and s
′′
i yields a
common intensity space that may be compared to others. The parameters αt, αs,
βt, and βs are chosen to place the tissue centres at appropriate locations in the
joint intensity space e.g. αs = 0.2, αt = 0.5, βs = 0.4, βt = 0.65. An example of
this scaling method is shown in Figure 4.7. Note that these parameters are chosen
with care to minimise the quantity of data points outside the [0, 1] range.
The ability to compare and contrast between scans and patients is clearly
useful. However, there needs to be some discussion on whether it is sensible to
linearly scale intensity values in this way.
As was outlined in subsection 3.4.2 it is clear that MR data requires some form
of intensity standardisation. However, the method employed must be suitable to
the pathology in question (e.g. [63, p. 7]). The method employed by Nyu´l and
Udupa [55] may not be suitable for this problem domain due to the assumption
of undesirable “tails” in the intensity distribution [55, p. 596]. In contrast, for
STIR acquisition and the myositis pathology, it is generally the high-intensity end
of the muscle distribution (with relatively low frequency) which helps indicate the
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Figure 4.7: Example of scaling joint histograms. Values shown are (STIR,T1)
intensities as transformed by Equation 4.21. (a) shows the transformation before
and after for a control subject, and (b) shows the same for a symptomatic case.
disease activity (oedema). Therefore it can be seen that Equation 4.20 provides a
suitable standardisation method for this problem domain.
4.14 Static segmentation (Step 1-L)
Since the joint histograms are now in a common space it is possible to select regions
using static masks (see Figure 4.8). Effectively this is segmenting the image based
on the joint T1 and STIR standardised intensities. In the majority of cases the
tissues are segmented well (e.g. Figure 4.9). The joint histogram masks allow
selection of the tissues within certain bounds specified by the masks.
Since the muscle tissue is of primary interest in the following chapters, the set
of locations x considered as muscle will be denoted M henceforth.
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Figure 4.8: (a) and (b) show segmentations of the intensity space into the two
tissues of muscle and fat, respectively. These are used in the proposed system. (c)
and (d) show the possibility of arbitrarily defined masks, where the tissue selection
criteria can be more refined if required.
a b c d
Figure 4.9: (a) and (b) show muscle and fat segmentations for an asymptomatic
control subject. (c) and (d) show the same segmentation process for a patient
with acute and chronic disease state (note the quantity of fat within the muscle).
4.15 Discussion
The pre-processing steps have been designed to be as rigorous and robust as pos-
sible, with respect to the pathology in question. In general the steps work without
manual intervention for the training and out of sample databases. However, in
some instances unexpected behaviour could occur.
Registration Step 1-C may fail if either of the two input slices have severe
MR artefacts, including intensity inhomogeneity as a result of the bias field. If
the subject moved during acquisition, then translation-only registration may be
inadequate and pre-processing Step 1-G to Step 1-L would be affected. Geometric
scaling in Step 1-D depends upon the correct parameter for DICOM key ‘Pixel
Spacing’. ROI selection in Step 1-E could fail if the T1 input has unexpected
geometry or unusual background intensity. Localisation of tissue centres in Step 1-
G may not work if the intensity distribution of tissues are extremely dispersed
or chaotic. Intensity scaling (Step 1-K) and adequate segmentation (Step 1-L)
depend upon the expected approximate location of tissues within the intensity
space.
In general, the pre-processing steps assume that the correct MRI protocol has
been followed, and that the subject has the normally expected anatomy.
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4.16 Conclusion
In this chapter, the necessary steps to pre-process the MRI scans have been
described. A semi-automatic segmentation process was designed to remove the
femur, based on the empirical data analysis of femur centroids, which was shown
to be comparable to a more labour-intensive process. A process for intensity
standardisation, suitable for the disease in question, has been introduced and it
has been shown to work via visual analysis of the joint intensity space. Import-
antly, this means all scans are in a common frame of reference, which will allow
generalised observations and comparisons to be made in the next chapter, leading
to disease quantification methods.
Chapter 5
Quantification of disease
In this chapter, the severity of oedema and fat infiltration is quantified such that
the disease state of a patient may be systematically measured. Since the level of
active disease is of immediate clinical interest, a method to quantify the severity
of oedema is presented first. A similar method is applied for the quantification of
fat infiltration.
5.1 Analysis of STIR intensity distribution for
oedema by cohort
By considering the standardised joint histogram from all subjects meeting a par-
ticular criteria, it is possible to learn what is expected in the average case and its
visualisation in the joint intensity space. With the benefit of this knowledge, an
approach is constructed based on the expected distribution shape.
Figure 5.1 shows the average joint histogram for all subjects in the training
database split into two cohorts. The first cohort is comprised of control subjects
a b
Figure 5.1: Comparison of the average joint histogram for different cohorts in the
training database. (a) is the average joint histogram of control subjects (n=9),
and (b) is the average joint histogram of all symptomatic patients (n=22).
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(volunteers assumed to be healthy) which represents what to expect in the ab-
sence of the disease. The second cohort, “symptomatic”, is comprised of patients
from the training database with confirmed oedema (i.e. acute disease state). The
average joint histogram is constructed by concatenating (s′′(x), t′′(x)) intensity
pairs from all pixels in the final ROI, for all slices, for all cases in the group under
consideration. 128×128 bins are used in the range [0, 1] and the joint histogram
is normalised such that the area under the surface is 1. In Figure 5.1 it is clear
that there is a difference in the joint histograms between cohorts. Generally, it
may be noted that the joint histogram for the control cohort is well-defined, with
one single value generally dominating the tissue clusters (in each dimension). In
comparison, the symptomatic cohort has poorly defined tissue clusters.
Figure 5.2 shows average joint histograms grouped by disease state. It is
assumed that the disease causes physical changes in the tissues that are represented
in the joint intensity space. This result has been used to guide the development
of disease specific metrics.
a b c d
e f g h
Figure 5.2: Comparison of the average joint histogram, grouped by oedema and
infiltration grade. (a)-(d) are average joint histograms for subjects with increasing
oedema. (e)-(h) are average joint histograms for subjects with increasing infiltra-
tion. Note that each subject may have some degree of oedema and fat infiltration,
so increasing severity in one state is not completely separable from the other.
Figure 5.3 is an analysis of the distribution for muscle tissue only. (a) suggests
that the presence of oedema does lead to a higher frequency of hyperintense pixels.
The effect can be seen clearly in Figure 5.4. This observation forms the basis for
selecting oedema in STIR images. It would be desirable to model the distribution
parametrically, and from the literature, Bartlett et al. [3] fitted a Guassian curve
to model the healthy and diseased tissue in the STIR histogram (see section 3.5).
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Figure 5.3: STIR muscle tissue histograms in the average case grouped by cohort.
All histogram data has been normalised. (a) is a comparison for all STIR muscle
signal. (b) and (c) show a Gaussian fit of the data for control and symptomatic
cohorts, respectively. (d) and (e) show the right-hand tail of the distribution (s′′ >
0.4 in this example) extracted and modelled with an exponential distribution.
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Figure 5.4: Histograms of STIR signal for muscle tissue by disease grade. (a)-(d)
show increasing thickness on the upper tail.
If X denotes a random variable with mean µ and standard deviation σ, then
it is assumed the distribution of tissue intensities IT is approximated by
IT ≈ X ∼ N(µ, σ2) (5.1)
where N is the normal distribution and has Probability Density Function (PDF)
Pµ,σ(x) =
1
σ
√
2pi
e−
(x−µ)2
2σ2 (5.2)
Figure 5.3 (b) and (c) show a Gaussian distribution fitted to the muscle intensities
for control and symptomatic cohorts, respectively. It is clear that, for the data
in the training database, the tissue is not adequately modelled by the Gaussian,
particularly in the right-hand region.
Another approach may be taken. Since it is known that acute disease (oedema)
gives hyperintense signal (i.e. the upper tail of the distribution) then it is logical
to conclude that only the upper tail of the distribution needs to be modelled.
Taking a threshold of the intensities (beyond the main peak) would result in a
histogram with gradually declining frequencies. It was assumed that this part of
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the distribution could be modelled effectively with an exponential distribution.
Again, if X denotes a random variable, then it is assumed the distribution of
tissue intensities IT is approximated by
IT ≈ X ∼ Exp(α, λ) (5.3)
where Exp is an exponential distribution, α is the location, and λ is the rate
parameter (the reciprocal of standard deviation). The exponential distribution
has PDF
Pα,λ(x) = λe
−λ(x−α), for x ≥ α. (5.4)
Figure 5.3 (d) and (e) show the histogram for STIR intensities above 0.4 with an
exponential distribution fitted. It was found that any threshold value marginally
beyond the main tissue peak can be sufficiently modelled with the exponential dis-
tribution. However, the value 0.4 was chosen since this is the assumed muscle peak
after intensity standardisation (see section 4.13). Table 5.1 shows a comparison
of the R2 statistic between the two different models.
Therefore this analysis has indicated a suitable approach to take in selecting
acute disease (oedema), using an exponential distribution as the basis.
R2 Control Symptomatic
Gaussian (whole) 0.769 0.768
Exponential (tail) 0.889 0.912
Table 5.1: Comparison of goodness of fit for Guassian and exponential distribu-
tions for STIR muscle intensity distributions.
5.2 Method for oedema selection
The standardised z -score is used to transform the STIR muscle intensities. The
z -transform takes the form
z =
x− µ
σ
(5.5)
where x is the original value, µ is the mean, σ is the standard deviation, and
z is the transformed value. In the case of a normal distribution N(µ, σ2) then
the z -score method transforms the data such that it follows the standard normal
distribution N(0, 1). The z -score may be thought of as the number of standard
deviations away from the mean of the distribution. This process is used to select
a candidate region of oedema that may then be quantified.
The z -transform will now be considered for an exponential distribution. If X
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is a random variable following an exponential distribution, denoted
X ∼ Exp(α, λ), then (5.6)
(X − α) ∼ Exp(0, λ). (5.7)
The PDF for this distribution is
P0,λ(x) = λe
−λx, for x ≥ 0. (5.8)
The mean and standard deviation are defined as
µ = σ = λ−1 =
1
N
∑
xi (5.9)
where N is the number of elements. Note that Equation 5.9 may be rearranged
to give
λ =
N∑
xi
. (5.10)
The z -transform for an exponential distribution may then be calculated as
z =
x− µ
σ
=
(x− 1
λ
)
1
λ
= λ(x− 1
λ
)
= λx− 1.
(5.11)
Now the z -score method will be applied to the problem of selecting a threshold
value which is consistent with a range of values for rate parameter λ. If M is
the set of pixel locations that represent the muscle which was found in the static
segmentation Step 1-L (section 4.14) then a mask of pixels whose intensities will
be modelled is given by
g1 =
{
(x, c(x)) : c(x) = 1 if x ∈M ∧ s′′(x) > γT , otherwise c(x) = 0
}
(5.12)
where γT is the intensity threshold, set to 0.4, and s
′′ is the standardised STIR
image, as computed in Step 1-K (section 4.13). Using Equation 5.10, the rate
parameter is calculated as
λ =
∑
x g1(x)∑
x [
(
s′′(x)−γT
)
g1(x)]
(5.13)
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and the z -score criteria is applied with
z1 =
{
(x, c(x))
}
,
c(x) =
1 if g1(x)[λ
(
s′′(x)− γT
)− 1] > g1(x)γZ
0 otherwise,
(5.14)
where γZ is a threshold value for the z -score, set to 0.1. Note that the actual
threshold value for a particular case may be found by adjusting Equation 5.11 to
account for threshold γT so that
x =
γZ + 1
λ
+ γT . (5.15)
When applied to the whole training database, the above method calculates a
thresholded value per STIR slice. The minimum threshold value was 0.431 and
the maximum was 0.624. This indicates the range of values taken by λ. Figure 5.5
shows the method applied to 3 cases from the training database. Comparison of
the method against a simple constant threshold method is provided in the last
row.
5.3 Region improvement
It is clear that whatever method is used to determine a threshold value, it is
conceivable that any arrangement of MR artefacts may be mistaken for oedema
or otherwise disguise it. For instance, Figure 5.5 (a) illustrates a control subject,
but the image is somewhat noisy and has appreciable bias field effects in the
upper half (residual from Step 1-F) which could be mistaken for acute disease.
Further, a large transverse blood vessel may yield hyperintense signal which is
not representative of the disease. In comparison, the symptomatic subject in (b)
has confirmed acute disease but the oedema has a softer appearance with less
hyperintense signal than (a). Figure 5.5 (c) shows how oedema (see arrow N5)
could look like a blood vessel (or artefact). Similarly, arrow N2 shows a blood vessel
that could be mistaken for oedema (or artefact). Therefore some verification must
be obtained from an experienced operator that the candidate region z1 does not
cover large regions of artefact. Some highlighting due to artefact is expected, and
cannot be realistically avoided, but so long as this remains at a baseline level then
the overall disease metric (discussed in the next section) is assumed to be valid.
Due to the z -transform applied in Equation 5.14, it is generally possible to over-
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Figure 5.5: A STIR slice from 3 separate cases in the training database are shown
in the first row. (a) is a control subject. (b) and (c) have confirmed acute disease
(active inflammation) status. The middle row shows the application of the method
from section 5.2 used on the slice above. The white region indicates z1, with the
faded slice behind. The last row illustrates a fixed threshold method, which may
be compared to the prior result. In (g), too much signal has been selected in the
control subject. In (h), the wide-spread oedema (indicated by N4) has not been
selected. (i) uses the same threshold value as (f). Notations: V1, V2, and V3
indicate the phase encoding direction and passes through the main blood vessel
present in the slice (it is dark for V3). Ghosting artefacts can be seen along V1.
Minor signal artefacts can be noticed in V2 and V3. The bright edge of N1 is an
MR artefact and does not represent oedema. N2 is assumed to be a transverse
blood vessel. N3 is an example of a blood vessel or MR artefact in the fat layer.
N4 is an example of broad oedema. N5 is an example of concentrated oedema.
R1, R2, and R3 indicate regions of z1 that are partially due to the vessel pulsation
artefacts (V1,V2,V3).
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estimate the candidate region but more difficult to under-estimate it. Thus, the
main scenario which must be considered is the removal of non-indicative regions
from z1.
From visual inspection of Figure 5.5, it can be seen that the presentation of
myositis is generally of interest when it occurs in groups, e.g. (e) and (f). Small,
individual objects in z1 tend not to indicate the presence of the disease but rather
a poor SNR, e.g. (d). Large objects in z1 tend to indicate some level of oedema
within a muscle.
Consider a new region z5, identical to z1 but where objects with fewer than
5 pixels have been removed. For noisy STIR images this reduces the quantity
of erroneous oedema pixels, however, the trade-off is that oedema may then be
under-estimated in subjects with acute disease. Since there is no data to provide
ground truth (with pixel-level granularity), it is only possible to compare overall
results from a series of experiments.
A number of different oedema regions will be formed from the initial region z1,
zn = z1 where objects with < n pixels are excluded, for n > 1. (5.16)
A suitable sample of the set of possible regions will be used in a test in section 5.5.
5.4 Definition of the oedema metric
A naive quantification may be formed with
ΨOedema =
∑
zi,
which yields the number pixels thought to represent disease for some region zi. In
pre-processing, the input slices were scaled such that each pixel represents 0.74mm
in each dimension. However, it is natural that subjects have a range of physical
leg size. Given that all subjects (control and symptomatic) will have at least
some baseline level of oedema, then subjects with a greater cross-sectional area of
muscle will tend to have greater values of ΨOedema. Clearly, the metric must be
normalised to account for the quantity of muscle present (not the overall number
of leg pixels, which would also contain fat tissue). The equation is re-written
ΨOedema =
∑
zi∑
M
(5.17)
where M is the set of muscle pixels, as before. ΨOedema now represents the per-
centage of muscle pixels thought to be oedema.
CHAPTER 5. QUANTIFICATION OF DISEASE 67
5.5 Correlation of the oedema metric with
acute disease
Since the cases in the training database have been graded by a medical expert
for disease severity, it is possible to measure the correlation between the metric
and expert opinion. (The ordinal scale is shown in Table 2.1, page 17). The
“expert grade” is used as a proxy for ground truth, albeit with relatively coarse
granularity when compared to a percentage metric. For the metric to be useful,
it must have positive correlation with the expert grading. However, deviations
are expected. It is generally understood that there is natural variation in expert
grading. For example, if a test were performed with 10 experts grading a set of
scans, the variation in the expert grade could be considerable. If the test were
repeated, a given expert may not reproduce the same grades (see Herlidou et al.
[30]). Fischmann et al. notes that clinically validated scales are subject to poor
inter- and intra-rater repeatability, and could be influenced by such factors as
fatigue and cooperation [19, p. 1648].
Figure 5.6 illustrates the correlation between the expert grade and oedema
metric ΨOedema using a set of sample regions {z1, z5, z9, z13}, generated using Equa-
tion 5.16. Statistics relating to this test are given in Table 5.2. The results show
an increase in the correlation coefficient and R2 statistics up to z9, meaning that
removing some small objects is indeed useful. z9 may be selected on the basis that
both the correlation coefficient and R2 gain their highest value for this region.
Results for z13 indicate that objects with fewer than 13 pixels (but more than 8)
meaningfully contribute to the ΨOedema metric and therefore should remain.
Region m c Pearson corr. R2
z1 0.0226 0.0965 0.6506 0.4233
z5 0.0231 0.0885 0.6651 0.4424
z9 0.0236 0.0804 0.6727 0.4526
z13 0.0238 0.0733 0.6707 0.4499
Table 5.2: Statistics for the the oedema metric using different regions of zi. m and
c are the slope and intercept, respectively, of the linear regression line. Pearson
corr. is the linear correlation coefficient.
In Figure 5.6 it is clear that values for the ΨOedema metric overlap between
grades. One possible reason for this is that only one set of data from a medical
expert was available. The variance of a single rater would have the effect of
“blurring” the class boundaries due to variation from the (unknown) ground truth,
although the overall trend would still be evident. A second possible reason for this
effect is due to the interaction between the “patchy” nature of the disease and the
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Figure 5.6: Linear regression between the ΨOedema metric and expert grade using
regions {z1, z5, z9, z13}.
fact that only one expert grade is assigned per subject. Since there is a total of 6
slices for each subject and the quantity of disease is not constant throughout the
leg, then there is a natural spread of ΨOedema values for every subject.
5.6 Towards validation of the oedema metric
Good correlation of ΨOedema with the expert grade is an encouraging sign. How-
ever, further testing will help indicate the level of robustness. The following three
scenarios must be considered to help validate the metric.
1. For a control subject who is rescanned in the same session, the metric must
have a similar value.
2. For a subject with confirmed oedema who is rescanned in the same session,
the metric must have a similar value. A longer period of time may mean a
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real change in the concentration of oedema.
3. For a patient with repeat scans over a long period of time, the change in
ΨOedema between scans must be seen to correlate with changes in disease
state.
Given the number of subjects available in the re-scan database, the following
tests cannot be considered a full validation. They will however strongly indicate
the potential of the method. The above scenarios will now be dealt with in turn.
5.6.1 Rescanned control
A control subject was rescanned in the same session, using the same slice loca-
tions. Table 5.3 shows the test results. Comparing values of T1 and T2 it can be
seen that the total number of pixels in the muscle region remained stable. The
difference between ΨOedema values has a minimum of 0.02% and a maximum of
1.04%. However, taking an average of all ΨOedema per scan, the mean values are
9.3% and 9.1% for first and second scans, respectively. The worst match in the set
is highlighted and shown in Figure 5.7. In general, the appearance between scans
is identical, however imaging artefacts resulting from vessel pulsation (vertically
above and below the blood vessel) do have some effect on the metric.
O1
a O2
a T1
b T2
b Ψ1
c Ψ2
c |Ψ1 −Ψ2| Jaccard Dice
3570 3639 41197 41470 0.0867 0.0878 0.0011 0.5325 0.6950
3791 3381 40082 39886 0.0946 0.0848 0.0098 0.3972 0.5686
3723 3399 38481 38395 0.0967 0.0885 0.0082 0.5416 0.7026
3283 3647 36258 36136 0.0905 0.1009 0.0104d 0.3485 0.5169
3699 3665 35247 34985 0.1050 0.1048 0.0002 0.5539 0.7129
2926 2543 33661 33421 0.0869 0.0761 0.0108 0.5384 0.7000
0.0934e 0.0905e
a Quantity of oedema, Oi =
∑
z9, subscripts denote scan 1 and 2.
b Quantity of muscle tissue, Ti =
∑
M , for scan 1 and 2.
c Ψi = ΨOedema, for scan 1 and 2.
d Denoted as the worst match in the set. Shown in Figure 5.7.
e Mean of the values above.
Table 5.3: Data table for rescanned control. The six rows in the table corres-
pond to the six slice locations (identical for both scans).
CHAPTER 5. QUANTIFICATION OF DISEASE 70
a b c
Figure 5.7: Diagram of the worst match for the rescanned control case. (a) is an
overlap digram showing the two z9 regions. The solid white contour shows the
final ROI. Intersection of the two regions is shown in white. (b) is the first scan
and (c) is the second. The view window has been cropped to show detail. Arrows
indicate regions with different intensity, possibly due to vessel pulsation.
5.6.2 Rescanned acute disease
A subject with confirmed oedema was rescanned during the same session. Note
that slice locations remained the same. Table 5.4 shows the data from the test on
the two regions of z9.
O1
a O2
a T1
b T2
b Ψ1
c Ψ2
c |Ψ1 −Ψ2| Jaccard Dice
8497 9344 54093 53994 0.1571 0.1731 0.0160 0.4934 0.6607
8870 6651 54421 53932 0.1630 0.1233 0.0397d 0.4830 0.6514
6725 7046 54088 53642 0.1243 0.1314 0.0070 0.3750 0.5455
7743 6153 53571 53212 0.1445 0.1156 0.0289 0.3342 0.5010
7473 6472 51526 50951 0.1450 0.1270 0.0180 0.4266 0.5981
6262 5275 48886 48563 0.1281 0.1086 0.0195 0.4250 0.5965
0.1437e 0.1298e
a Quantity of oedema, Oi =
∑
z9, subscripts denote scan 1 and 2.
b Quantity of muscle tissue, Ti =
∑
M , for scan 1 and 2.
c Ψi = ΨOedema, for scan 1 and 2.
d Denoted as the worst match in the set. Shown in Figure 5.7.
e Mean of the values above.
Table 5.4: Data table for rescanned acute disease case. The six rows in the
table correspond to the six slice locations (identical for both scans).
In this test, the difference in values of ΨOedema between scans has a minimum
of 0.7% and a maximum of 3.97%. The worst match in the set was judged by
the absolute difference of ΨOedema between scans. This slice location from both
scans is shown in Figure 5.8. Notice that (b) and (c) are nearly identical except
for slight, yet distinct, differences in intensity. This has caused a change in the
z9 region and therefore decreased the Jaccard score (Table 5.4). However, the
location of the z9 region is similar in both scans, supported by a relatively high
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Figure 5.8: Diagram of the worst match in the rescanned acute disease case. (a)
is an overlap digram showing the two z9 regions. The solid white contour shows
the final ROI. Intersection of the two regions is shown in white. (b) is the first
scan. (c) is the second scan. The view window has been cropped to show detail.
Notice that (b) has somewhat pronounced oedema compared to (c). Two specific
changes are shown at the arrows.
Dice score.
Taking an average of all ΨOedema per scan, the mean values are 14.4% and 13.0%
for first and second scans, respectively. It is difficult to interpret the meaning
of the decrease, since the test would ideally represent no change in the acute
disease state. The change in intensity could be some artefact of the MRI machine.
However there are changes in intensity, which can be seen visually. The decrease
in ΨOedema is in line with that visual perception.
5.6.3 Longitudinal rescans
In the re-scan database there are 2 subjects who were scanned on 3 separate
occasions, and 1 subject was scanned on 2 different occasions. These scans have
been used to identify the change in disease over time.
Summarised data for the test is shown in Table 5.5 for each of the re-scanned
subjects. The data is also plotted in Figure 5.9 so that the change over time is
more apparent.
Although there is too little data to perform statistical analysis, it is worth
noting that in the cases available, not only does the average metric ΨOedema (for 6
slices) appear to be useful, but so does the range of ΨOedema.
Since the scans have been taken at different times, it is not possible to compare
oedema regions (z9) directly. However, the level of disease can be visually assessed.
Figure 5.10 shows sample slices from the three cases.
CHAPTER 5. QUANTIFICATION OF DISEASE 72
Case Mark Day Average Min (error) Max (error)
1 ⊕ 0 0.2274 0.0172 0.0169
1 ⊕ 179 0.1136 0.0162 0.0279
1 ⊕ 298 0.1133 0.0144 0.0202
2 × 0 0.1177 0.0149 0.0225
2 × 122 0.1447 0.0200 0.0204
2 × 321 0.1157 0.0072 0.0140
3 − 0 0.1138 0.0163 0.0231
3 − 119 0.1087 0.0078 0.0090
Table 5.5: Data table for longitudinal rescans. This data is
plotted in Figure 5.9.
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Figure 5.9: Oedema metric for longitudinal cases. Cases are marked (⊕,×,−) for
cases 1, 2, and 3, respectively. The lower error bar is the minimum. The upper
error bar is the maximum. The mark shows the mean of all 6 slices.
5.6.4 Discussion
In section 5.1 it was found that an exponential distribution may be used to model
the upper tail of the STIR distribution, where acute disease is expressed. The
automatic selection of the diseased region z1 was detailed (section 5.2) and an
improvement to the region suggested in section 5.3. The ΨOedema metric was
formed (section 5.4) and found to have positive correlation with expert grading
(section 5.5) and the best refined region was found to be z9. In this section
(section 5.6), results have been presented that strongly suggest that the ΨOedema
metric is sufficiently robust to track changes in disease state. With consideration to
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Figure 5.10: Examples for multiple time-points for longitudinal cases. (a)-(c) are
a single slice from time-points of the case marked ⊕ (in order, left to right). Simil-
arly, (d)-(f) are single slices for case marked ×. (g) and (h) are single slices for case
marked −. The visual assessment for each subject through time is commensurate
with the time-series profile of Figure 5.9. Notice: (a) is clearly the worst case
and has the highest (average) metric value of 0.2274. By inspecting Table 5.5, it
is reasonable to assume that the first scan for case 3 (mark −) would have sim-
ilar disease to either of the last two scans for case 1 (⊕), and indeed (g) may be
assessed with (b) and (c).
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the validation tests, it is now assumed that the metric is, on average, representative
of acute disease. This can only be said when certain conditions of the data are
met. One such condition is that adequate intensity separation exists in the STIR
slice between fat and muscle tissues. This is normally expressed as adequate “fat
suppression” in the literature. Slices that are blurred or have poor SNR may be
acceptable so long as the prior condition is met. Importantly, the metric is only
valid once major blood vessels have been excluded from analysis.
Some consideration must be made to the small number of test cases available.
Given a larger database, it would be possible to calculate confidence intervals for
the metric. In the absence of enough suitable data, the test approach has been
conducted as rigorously as is possible.
It must be expressed that all acquisitions were performed in a clinical setting
and therefore the quality of scans is representative of what could normally be
expected in most hospitals. Therefore, this is an encouraging sign suggesting it
could be implemented and used in a practical setting.
5.7 Analysis of T1 intensity distribution for fat
infiltration by cohort
Fat infiltration is where muscle cells have been replaced by fat as a result of cell
damage. The damage is caused by the build up of inflammation, as a result of
the disease. Therefore, the acute disease (oedema) may reduce in severity, but
the chronic disease (fat infiltration) is not expected to reduce. It is assumed that
fat cells replacing muscle cells will lead to a slightly elevated T1 muscle signal.
The explanation for this is that, for a given voxel in the acquisition matrix, the
number of fat cells (out of the total number of cells) has increased and that their
summed contribution elevates the signal. The intensity is raised as the fat appears
brighter than the muscle on T1 scans. Investigations of the joint intensity space
appear to confirm this. Indeed, fat infiltration lying within the muscle does not
have the same brightness as fat around the leg. Visual inspection of the joint
intensity space for subjects with confirmed infiltration does suggest a broadening
of the T1 signal around the muscle cluster (see Figure 5.2 on page 59). This forms
the theoretical basis for the selection procedure.
Figure 5.11 shows the distribution for T1 muscle pixels. The Gaussian distri-
bution fits the data moderately better than anticipated and therefore the Jarque-
Bera test was employed for verification. The test rejected the null hypothesis for
both control (p < 0.001) and symptomatic (p < 0.001) cohorts. Table 5.6 shows
the goodness of fit tests for the Gaussian and exponential distributions.
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Figure 5.11: T1 muscle tissue histograms in the average case grouped by cohort.
All histogram data has been normalised. (a) is a comparison for all T1 muscle
signal. (b) and (c) show a Gaussian fit of the data for control and symptomatic
cohorts, respectively. (d) and (e) show the right-hand tail of the distribution (t′′ >
0.15 in this example) extracted and modelled with an exponential distribution.
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R2 Control Symptomatic
Gaussian (whole) 0.580 0.698
Exponential (tail) 0.775 0.908
Table 5.6: Comparison of goodness of fit for Guassian and exponential distribu-
tions for T1 muscle intensity distributions.
Modelling the upper tail of the distribution with the exponential model is
satisfactory.
To select a suitable region of suspected fat infiltration, Equation 5.12, Equa-
tion 5.13, and Equation 5.14 are modified for the T1 signal:
g1 =
{
(x, c(x)) : c(x) = 1 if x ∈M ∧ t′′(x) > γT , otherwise c(x) = 0
}
(5.18)
where γT is the intensity threshold, set to 0.15, and t
′′ is the standardised T1
image. The rate parameter may be calculated with
λ =
∑
x g1(x)∑
x [
(
t′′(x)−γT
)
g1(x)]
(5.19)
and the region of suspected fat infiltration is
z1 =
{
(x, c(x))
}
,
c(x) =
1 if g1(x)[λ
(
t′′(x)− γT
)− 1] > g1(x)γZ
0 otherwise,
(5.20)
where γZ is a threshold value for the z -score, set to −0.31.
The above method is applied in a selection of cases in Figure 5.12. The differ-
ence between using an exponential distribution and a fixed threshold, is smaller
than for the oedema metric (c.f. Figure 5.5). The intensity of T1 slices are gen-
erally more reliable than STIR. However, a fixed threshold method did not yield
satisfactory results for the entire training database.
5.8 Definition of the infiltration metric
As with the oedema metric, it is clear that different subjects have a range of
physical leg size and therefore the infiltration metric must account for the cross-
sectional area of muscle present in the slice.
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Figure 5.12: A T1 slice from 3 separate cases in the training database are shown
in the first row. (a) is a control subject. (b) and (c) have mild and moderate
fat infiltration, respectively. The middle row shows the application of the method
from section 5.7 used on the slice above. The white region indicates z1, with the
faded slice behind. The last row illustrates a fixed threshold method, which may
be compared to the prior result. Notations: Arrow N1 shows slightly too much
selection for the control case. Arrow N2 shows the effect of the bias field on the
selection method.
Therefore, the infiltration metric is formulated
ΨInfil =
∑
z1∑
M
(5.21)
where “Infil” is short for infiltration, M is the set of muscle pixels, as before, and
z1 is found with Equation 5.20.
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5.9 Correlation of the infiltration metric with
chronic disease
Linear regression of the infiltration metric against expert grading is shown in
Figure 5.13. The correlation coefficient was 0.821, linear regression slope m =
0.056 with intercept c = 0.147, and the fit had an R2 = 0.6744.
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Figure 5.13: Linear regression between the ΨInfil metric and expert grade using
region z1.
Differentiating between normal and mild levels of fat infiltration is difficult, as
shown by the small increase in average value between these grades in the figure.
It is expected (e.g. in control subjects) that a thin layer of fat separates some of
the muscles, and therefore detecting the difference slightly above the “normal”
baseline is subject to error.
Very severe fat infiltration may not be estimated correctly by the method
detailed. A voxel that is entirely occupied by fat cells will have hyperintense
signal, and therefore not expected to be a member of M . In these cases, the
original muscle shape is hidden, and therefore it is extremely difficult to estimate
the quantity of muscle that “should” be present.
5.10 Validation for the infiltration metric:
rescanned control
As with the oedema metric, further testing will help indicate the level of robust-
ness for the infiltration metric. The conditions for the test were replicated as in
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subsection 5.6.1. Table 5.7 shows the data from the validation test and Figure 5.14
shows the worst match in the case.
I1
a I2
a T1
b T2
b Ψ1
c Ψ2
c |Ψ1 −Ψ2| Jaccard Dice
3867 4839 41197 41470 0.0938 0.1166 0.0228 0.4609 0.6310
4802 4799 40082 39886 0.1198 0.1203 0.0005 0.4160 0.5876
4211 5574 38481 38395 0.1094 0.1451 0.0357d 0.4683 0.6379
4476 4288 36258 36136 0.1234 0.1186 0.0047 0.4042 0.5757
4637 4870 35247 34985 0.1315 0.1392 0.0076 0.4829 0.6513
3410 3542 33661 33421 0.1013 0.1059 0.0046 0.4384 0.6096
0.1132e 0.1243e
a Quantity of infiltration, Ii =
∑
z1, subscripts denote scan 1 and 2.
b Quantity of muscle tissue, Ti =
∑
M , for scan 1 and 2.
c Ψi = ΨInfil, for scan 1 and 2.
d Denoted as the worst match in the set. Shown in Figure 5.14.
e Mean of the values above.
Table 5.7: Data table for rescanned control (infiltration test). The six rows in
the table correspond to the six slice locations (identical for both scans).
a b c
Figure 5.14: Diagram of worst match in rescanned control case for the infiltration
metric. (a) is an overlap digram showing the two z1 regions. The solid white
contours show the leg mask and femur. Intersection of the two regions is shown
in white. (b) is the first scan. (c) is the second scan. The view window has been
cropped to show detail. Note that (c) is blurred compared to (b).
5.11 Conclusion
Two disease-specific metrics have been developed to measure the key clinical
presentations of inflammatory muscle disease: oedema and fat infiltration. The
metrics were designed from the expected distribution of diseased muscle tissue in
the joint histogram. Based on the validation tests, they have been shown to have
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a good level of repeatability. Moderately strong correlation with expert grade
suggests that the computed quantities are in line with expert medical opinion.
Class overlap may be explained by the effect of rater variance and the fact that
only a single expert grade is available per case. Given that all scans were ac-
quired clinically, the methods presented are suitable for application in a clinical
environment.
In the following chapter, the disease metrics will be used in conjunction with
statistical measures for the task of automatic classification.
Chapter 6
Classification of disease severity
The disease metrics from Chapter 5 are based on the hyperintense signal of muscle
tissue for T1 and STIR modalities. In this chapter, properties of the joint distribu-
tion are utilised, together with the oedema and infiltration metrics, for automatic
classification on a per slice basis.
6.1 Premise for the approach
As known, the joint histogram represents the distribution of tissue intensities.
The shape of the distribution appears to represent the disease state, as shown in
Figure 5.2 (page 59). It is assumed that the change in distribution is caused by
physical changes occurring in the tissues. This is supported by the clinical reason
for imaging the patient in the first instance: to show the severity of oedema and
fat infiltration. In the previous chapter, two disease metrics, ΨOedema and ΨInfil,
were designed to model the distribution for these disease characteristics. These
metrics are based on the observed differences in distribution above a threshold
value for muscle tissue. However, the whole joint intensity space contains a great
deal of data that is not used in either of the disease metrics. While these metrics
may be the most important from a clinical point of view, it is assumed that other
regions in the joint intensity space may carry “information” on the disease that
could also be harnessed.
Knowledge of the most important regions in the joint intensity space would
be of benefit to help design a CAD system, where the output classification is
expected to match the expert grade. The two grades (oedema and fat infiltration)
are treated as separate classification problems, since it is known that theses disease
characteristics can be independent. It is expected that a system may be devised
with the training database and tested on the out of sample database for realistic
clinical results.
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6.2 Selected statistical measures
Measures were selected in order to attempt to describe the broad shape and charac-
teristics of the underlying data. The measures are: standard deviation, skewness,
kurtosis, and gini coefficient.
Given a sequence x = x1, x2, . . . , xn with the number of elements n, then the
standard deviation is defined as
σ =
 1
n
n∑
i=1
(xi − µ)2
 12 . (6.1)
This measure is used on the presumption that deviations in the distribution may
have some correlation with disease severity.
Skewness is defined as
s =
1
n
∑n
i=1 (xi − µ)3
σ3
, (6.2)
which is negative for long left-tail distributions, 0 for symmetric, and positive for
long right-tail distributions. The same property may be measured more robustly
with another statistic called the medcouple, which may be computed in O(n log n)
time [9].
The kurtosis is defined as
k =
1
n
∑n
i=1 (xi − µ)4
σ4
. (6.3)
This measures how “pinched” the distribution is with respect to the standard
normal distribution.
The Gini coefficient is a statistical measure of concentration [54; 11] and it is
defined as
G =
∑n
i=1 (2i− n− 1)x(i)
n2µ
, (6.4)
where x(i) denotes the ith element in the ordered sequence of x (ascending).
The measures described above may be calculated on any sequence x. However,
since the joint intensity space is two dimensional, data from a given region must
be represented by a sequence, in some manner. The approach taken here is to use
a column or row sum over the region to yield a sequence on which to calculate the
measures.
A formal definition of the joint histogram was presented earlier (Equation 4.4,
page 39). Given that the joint histogram has already been computed, it is con-
venient to consider it as a matrix Hi,j where i indexes rows and j indexes columns.
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Hi,j =

H1,1 H1,2 · · · H1,J
H2,1 H2,2 · · · H1,J
...
...
. . .
...
HI,1 HI,2 · · · HI,J
 (6.5)
where I = 128, representing maximum STIR intensity, and J = 128, representing
maximum T1 intensity. A rectangular ROI on Hi,j will be denoted R(I1, I2, J1, J2)
which specifies the region where I1 ≤ i ≤ I2 and J1 ≤ j ≤ J2. The column sum
for a region may then be found with
xk+1 =
I2∑
i=I1
Hi,k+J1 for k = 0, . . . , J2 − J1 (6.6)
where x1 would be the first column from the region. The meaning for a single
column is: the sum of frequencies for any joint intensity where the (discretised) T1
signal was fixed but the (discretised) STIR signal was between certain limits. The
sequence xi represents a contiguous range of column sums. Similar to Equation 6.6,
the row sum may be found with
xk+1 =
J2∑
j=J1
Hk+I1,j for k = 0, . . . , I2 − I1, (6.7)
where x1 would be the first row from the region. The meaning for a single row is:
the sum of frequencies for any joint intensity where the (discretised) STIR signal
was fixed but the (discretised) T1 signal was between certain limits. The sequence
xi represents a contiguous range of row sums.
Use of carefully selected regions, R(I1, I2, J1, J2), allow two-dimensional data to
be aggregated into a sequence, where the univariate statistical measures (presented
above) may be applied. Which regions to use are then of primary interest.
6.3 Method for scoring the intensity space
Initial work using the selected features on three broad regions of the joint histo-
gram space (rectangular regions covering the muscle, the fat, and the whole intens-
ity space) indicated that using the raw numbers was not powerful. As discussed
in the previous chapter, it was recognised that the difference in distribution is
important, particularly above the muscle centre value for each dimension. There-
fore, it was assumed that a scoring system that encompassed some reference to the
signal intensity would be useful. In this case, a straightforward scoring system is
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applied to the joint histogram. A T1-scored feature is where the joint histogram
matrix Hi,j is multiplied by the square of the T1-bin index such that
Hˆi,j = Hi,j ◦

12 22 · · · 1282
...
...
. . .
...
12 22 · · · 1282
 (6.8)
where ◦ is element-wise (Hadamard) multiplication. The selected measures are
calculated on a region of Hˆi,j. Similarly, STIR-scored features use the square of
the STIR-bin index such that
Hˆi,j = Hi,j ◦

12 · · · 12
22 · · · 22
...
. . .
...
1282 · · · 1282
 . (6.9)
In both cases, the histogram is normalised such that volume under the surface
(defined by region R) is unity. Further testing indicated this scoring system to be
more powerful than using raw frequencies.
6.4 Feature vector template
Table 6.1 shows the initial feature vector. Note that the features are only calcu-
lated over the region currently being considered, as shown by the re-indexing in
Equation 6.6 and Equation 6.7.
Scoring: T1-scored STIR-scored T1-scored STIR-scored
Sum type: Row-sum Column-sum
Statistic: k s G σ k s G σ k s G σ k s G σ
Element: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
Table 6.1: Layout of the feature vector.
6.5 Evaluation of region performance
To establish which regions in the joint histogram were the most suitable, a test
was conducted. The aim of the test was to find a general trend in the regions
being considered. Table 6.2 defines the regions that were used in the test.
Each region (1 through 16) was considered in turn. The feature vector (as
detailed in section 6.4) was constructed by considering only the data from the
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No. Region Area Primary tissue
1 R(52, 77, 20, 45) 676 Muscle
2 R(52, 94, 20, 62) 1849 Muscle
3 R(52, 111, 20, 79) 3600 Muscle
4 R(52, 128, 20, 96) 5929 Muscle
5 R(26, 77, 13, 26) 728 Muscle
6 R(18, 86, 9, 30) 1518 Muscle
7 R(9, 94, 5, 35) 2666 Muscle
8 R(1, 103, 1, 39) 4017 Muscle
9 R(26, 52, 58, 84) 729 Fat
10 R(26, 69, 41, 84) 1936 Fat
11 R(26, 86, 24, 84) 3721 Fat
12 R(26, 103, 7, 84) 6084 Fat
13 R(20, 32, 77, 90) 182 Fat
14 R(13, 39, 71, 96) 702 Fat
15 R(7, 45, 64, 103) 1560 Fat
16 R(1, 52, 58, 109) 2704 Fat
Table 6.2: Definition of the regions used in the region importance test. Regions
1-4 increase in size but the top-left corner is located at the muscle cluster centre.
Regions 5-8 expand with the muscle centre located in the middle. Regions 9-12
increase in size but the top-right corner is located at the fat cluster centre. Regions
13-16 expand with the fat centre located in the middle. Area is in units squared.
defined region. Using the training database, 186 instances of the feature vector
were computed for the region. Since two expert grades are available per case (one
for oedema, one for fat infiltration), two classification problems are to be solved
and therefore two output datasets are generated per region. In total, there are 32
datasets (16 regions, 2 classifications).
The classifier for this test was chosen to be Naive Bayes. This classifier has
been used extensively in the literature and it has been shown to work well in a
variety of domains [10]. It is popular due to its robustness [73] and it generally
gives better predictive accuracy, as compared to more sophisticated methods [7].
The dataset is loaded and a subset selection algorithm [24] is applied. 10-fold
cross validation is used with Naive Bayes. The weighted average of the AUROC
is used to judge the overall performance of the region, along with TPR, FPR,
and the F-measure. The F-measure is defined as the harmonic mean of TPR and
precision.
The above test was repeated 10 times and the average performance taken. In
order to make the test more robust, each run was randomised (e.g. fold location).
Region performance per test type is summarised in Table 6.3. The category of
the features selected by the evaluator is shown in Table 6.4.
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Region Test type TPR FPR F-measure Weighted ROC area
1 infiltration 0.7891 0.0704 0.7890 0.9502
2 infiltration 0.7716 0.0762 0.7705 0.9406
3 infiltration 0.7436 0.0855 0.7422 0.9362
4 infiltration 0.7321 0.0893 0.7303 0.9328
5 infiltration 0.7146 0.0951 0.7085 0.9356
6 infiltration 0.7303 0.0900 0.7298 0.9334
7 infiltration 0.7382 0.0872 0.7351 0.9327
8 infiltration 0.7282 0.0906 0.7240 0.9274
9 infiltration 0.5191 0.1603 0.5057 0.7858
10 infiltration 0.6558 0.1146 0.6478 0.8926
11 infiltration 0.7859 0.0714 0.7846 0.9403
12 infiltration 0.8240 0.0588 0.8219 0.9483
13 infiltration 0.4501 0.1833 0.4150 0.7396
14 infiltration 0.5174 0.1607 0.4949 0.7576
15 infiltration 0.4983 0.1673 0.4742 0.7881
16 infiltration 0.5075 0.1642 0.4867 0.8025
1 oedema 0.7250 0.0915 0.7274 0.9070
2 oedema 0.7264 0.0912 0.7271 0.9234
3 oedema 0.7461 0.0846 0.7451 0.9288
4 oedema 0.7321 0.0892 0.7302 0.9076
5 oedema 0.5679 0.1439 0.5736 0.8272
6 oedema 0.5863 0.1379 0.5930 0.8616
7 oedema 0.6119 0.1294 0.6167 0.8568
8 oedema 0.6689 0.1103 0.6708 0.9004
9 oedema 0.5919 0.1360 0.5816 0.8298
10 oedema 0.6246 0.1251 0.6202 0.8589
11 oedema 0.6533 0.1156 0.6449 0.8777
12 oedema 0.6946 0.1019 0.6948 0.8955
13 oedema 0.4532 0.1822 0.4296 0.7464
14 oedema 0.5712 0.1429 0.5660 0.8153
15 oedema 0.5761 0.1414 0.5738 0.8195
16 oedema 0.5924 0.1358 0.5881 0.8371
Table 6.3: Region performance data: all figures are an average of 10 runs.
Regions Test type T1-scored STIR-scored Row-sum Column-sum
1-8 infiltration 330 210 170 370
9-16 infiltration 260 370 270 360
1-8 oedema 380 380 470 290
9-16 oedema 330 440 490 280
Table 6.4: Tally of selected features by region and category. Note that the evalu-
ator may select any number of features.
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Careful analysis of these tables reveals some important details that should be
discussed before moving on.
In general, Table 6.4 shows that, on average, the evaluator preferred row-
summed features for classifying the oedema grade, irrespective of the exact region
used. The reverse is true for classifying infiltration grade. STIR-scored features
were generally preferred for regions 9-16 (over the fat cluster). Interestingly, T1-
scored features over the muscle cluster (regions 1-8) were preferred for classifying
infiltration, which supports the method used in section 5.7 to help calculate ΨInfil.
Such preference for classifying oedema is not so clear for STIR-scored features over
the muscle (regions 1-8), however the overall preference for row-summed features
does give strong support for the method developed in section 5.2 to compute
ΨOedema.
Table 6.3 indicates that oedema classification is generally a more difficult task
than infiltration, as shown by the generally higher FPR. Regions 1-8 for oedema
suggest that larger regions for oedema classification are useful, given that the
average ROC area correlates with the region size. The lower value for region 4
could be caused by the relative paucity of data-points in the upper portion of the
distribution for some image pairs. Region 3 has the best performance. For the
classification of infiltration, the results suggest more than one region is applicable.
Regions 1-8 perform well, but the weighted ROC area is negatively correlated with
region size, suggesting the most useful data is near the cluster centre.
6.6 Correlation as a disease feature
With careful consideration, it is possible to hypothesise a change in correlation
between T1 and STIR signal for control subjects versus symptomatic subjects. In
general, correlation estimates the degree of dependence of one variable on another
variable. When the relationship is dependent, the correlation may be strong, but
when the relationship is independent, the correlation is expected to be close to
zero. Since corresponding elements in the T1 and STIR signals are expected to
be a sample of the same physical space, and therefore the same material, it is
expected that some baseline level of correlation exists between the two signals.
However, due to the difference in acquisition sequences, the relationship is not
expected to be linear. Indeed, to consider a range of tissue types (ordered by their
expected signal intensity) for the two modalities, it is clear that their order is not
simply reversed. If the samples are limited to a single tissue class, however, then
the relationship between the two modalities should be more clear and a baseline
level of correlation may be obtained for the control case. In the presence of the
disease, a divergence from the baseline level of correlation is expected. This can
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easily be seen due to the presence of hyperintense STIR signal for inflamed muscle
tissue, with limited to no change in the corresponding T1 signal. As a possibly
confounding issue, it can also be seen that a slightly elevated T1 signal, in the
case of mild to moderate fat infiltration, would also affect the correlation statistic.
However, conceding that possibility, it is still expected to represent a divergence
from the control case, but may be non-specific to the disease state.
Given the above hypothesis, and a fundamental reason for its function, the
Spearman rank correlation coefficient is included in the feature vector. It is cal-
culated on corresponding samples for muscle tissue. The Spearman correlation
coefficient is calculated with two equal length sequences such that
ρ = 1− 6
∑
[(x(i) − y(i))2]
n(n2 − 1) (6.10)
where x(i) is the rank for the ith element in a sequence x, y(i) is the rank for the
ith element in another sequence y, and n is the cardinality of x. In this case, the
disease specific feature was chosen to operate on a subset of muscle pixels,
q = {m : m ∈M ∧ s′′(m) > 0.4 ∧ t′′(m) > 0.15}, (6.11)
where M is the set of muscle pixel locations, as before. ρ is then calculated on
the two sequences for locations in q.
Some caution may be warranted when using statistical measures and, in the
end case, it has been advised that a visible relationship is established [2].
6.7 Configuration for classification
Table 6.5 and Table 6.6 show the layout of the oedema and infiltration feature
vectors, respectively.
Data: Region 3 Muscle pixels M Muscle pixels M
Feature: {Table 6.1} ρ ΨOedema
Element: 1-16 17 18
Table 6.5: The oedema feature vector.
Data: Region 4 Region 8 Muscle pixels M Muscle pixels M
Feature: {Table 6.1} {Table 6.1} ρ ΨInfil
Element: 1-16 17-32 33 34
Table 6.6: The infiltration feature vector.
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Feature no. Feature Region Sum type Scoring
1 k, kurtosis 3 row T1
10 s, skewness 3 column T1
12 σ, std.dev. 3 column T1
13 k, kurtosis 3 column STIR
16 σ, std.dev. 3 column STIR
17 ρ, correlation M - -
18 ΨOedema M - -
Table 6.7: Features selected from the oedema vector after dimensionality reduc-
tion.
Feature no. Feature Region Sum type Scoring
13 k, kurtosis 4 column STIR
25 k, kurtosis 8 column T1
29 k, kurtosis 8 column STIR
34 ΨInfil M - -
Table 6.8: Features selected from the infiltration vector after dimensionality re-
duction.
Region 3 was chosen for the oedema vector as this region showed the best
performance in section 6.5. In an initial test, region 4 (alone) was selected for the
infiltration vector, however poor classification performance resulted. In visualisa-
tion of the feature space, it became apparent that the majority of features from
this region were not distinct. Therefore, region 8 was appended, which also had
good performance in section 6.5.
Note that both vectors have the rank correlation of muscle signal, ρ (sec-
tion 6.6). The oedema vector has disease metric ΨOedema (section 5.4), and the
infiltration vector has ΨInfil (section 5.8). It is assumed that the combination of
standard statistical measures and disease specific metrics will result in a powerful
classifier.
Feature vectors were constructed for the training database and dimensionality
was reduced using the subset selection evaluator [24], as before. Features were
scored out of 10 folds (k-fold validation). Features scoring less than 100% were
dropped from further analysis. Table 6.7 and Table 6.8 show the selected features
for oedema and infiltration, respectively. Note that, with “competition” from
other features, the ΨOedema and ΨInfil metrics developed in the previous chapter
were both chosen. Correlation (ρ) was chosen for oedema but not for infiltration.
A total of 11 features were chosen out of a possible 52.
Figure 6.1 shows the feature space for feature 1 (based on kurtosis) against
feature 18 (ΨOedema). Since it is clear that feature 1 generally decreases with
increasing ΨOedema then negative correlation is present. Note that, in general,
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Figure 6.1: Oedema feature space for
features 1 and 18.
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Figure 6.2: Oedema feature 1 against
expert grade with linear regression line.
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Figure 6.3: Oedema feature space for
features 17 and 18.
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Figure 6.4: Oedema feature 17 against
expert grade with linear regression line.
the “monotonicity” with respect to disease grade is maintained (i.e. disease grade
order is maintained). Figure 6.2 shows feature 1 against the expert grade with
a linear regression fit for comparison. Note that it appears to help separate the
Normal and Mild grades.
Figure 6.3 shows the feature space for feature 17 (rank correlation) against
feature 18 (ΨOedema), and Figure 6.4 shows feature 17 against expert grade. As
discussed in section 6.6, it appears that the rank correlation does reduce in the
presence of oedema, however there is some overlap present between classes.
Since the most “visibly strong” features have been discussed, the other selected
features from Table 6.7 are not detailed further. Many of the features have a
moderate degree of overlap between grades, but some trend can be seen.
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Figure 6.5: Infiltration feature space for
features 25 and 34.
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Figure 6.6: Infiltration feature 25
against expert grade with linear regres-
sion line.
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Figure 6.7: Infiltration feature space for
features 29 and 34.
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Figure 6.8: Infiltration feature 29
against expert grade with linear regres-
sion line.
Figure 6.5 shows the relationship between feature 25 from the infiltration vec-
tor and feature 34 (ΨInfil). Despite overlap between the grades, it can be seen that
the feature tends to decrease while the percentage of fat infiltration increases. Fig-
ure 6.6 shows feature 25 against the infiltration grade, with a linear regression line
fitted. Figure 6.7 shows feature 29 against feature 34 (ΨInfil), again exhibiting the
same trend, although the spread is mildly different when compared to Figure 6.5.
Figure 6.8 shows feature 29 against infiltration grade, with linear regression line,
for reference.
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6.8 Classification results for the training
database
Instances were 10-fold cross validated on the training database, comprised of 186
instances. For comparison, two different classifiers have been used: Naive Bayes
[10] and AdaBoost [22].
The Naive Bayes classifier was chosen since the selected features from the eval-
uator (for both oedema and infiltration) generally had the appearance of slowly-
varying probabilities across the feature space (for different classes). As discussed
in section 6.5, Naive Bayes is known to perform well in a variety of domains. Des-
pite the naive assumption of conditional independence between features, it is this
property that reduces the variance of its predictions [7, p. 1782].
The AdaBoost classifier was chosen as an alternative to Naive Bayes. AdaBoost
is a popular ensemble method which has been empirically shown not to over-fit the
training data [73], which was considered important for robustness, especially with
regards to out of sample data. In this case, the tree classifier J48 (also known as
C4.5 [60]) was used as the weak classifier for AdaBoost. J48 was chosen because
it was clear that in some feature spaces, some division would allow adequate
separation of one or more of the classes. It was assumed that AdaBoost would
outperform Naive Bayes.
For classificaiton of oedema, Table 6.9 shows the confusion matrix for each
classifier, and Table 6.10 shows a comparison of their performance. Both classi-
fiers perform well, however AdaBoost achieves equal or better performance in all
classes. Careful inspection of Table 6.9 reveals that each classifier predicts the
class correctly on average, but there is moderate “jitter” or overlap. In the event
that the classifier predicts the wrong class, and considering that the output class is
nominal, then it would be particularly desirable to measure the rate with which a
given classifier predicts “within one” of the real class. For instance, it is preferable
that a subject with Moderate disease be classified as Severe, or possibly Mild, but
not Normal. By this measure, the Naive Bayes classifier scored 177 (95%), and
AdaBoost scored 171 (92%).
For classification of infiltration, Table 6.11 shows the confusion matrix for
each classifier, as before, and Table 6.12 shows a comparison of their performance.
Clearly, both classifiers have difficulty with the Mild infiltration class. AdaBoost
achieves a greater TPR but slightly worse FPR as compared to Naive Bayes. The
“within one” score is 185 (99%) for Naive Bayes and 178 (96%) for AdaBoost.
Note that the “within one” score is generally high compared to the TPR,
as found in Table 6.10 and Table 6.12. To explain this difference note that the
TPR is calculated based on 1 possible correct outcome and 3 possible incorrect
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Real Naive Bayes AdaBoost
0 1 2 3 0 1 2 3
0 (Normal) 17 6 1 0 22 2 0 0
1 (Mild) 5 42 12 7 2 54 3 7
2 (Moderate) 0 9 31 2 0 5 35 2
3 (Severe) 0 1 7 46 0 8 3 43
Table 6.9: Confusion matrices for oedema classification using the training data-
base.
outcomes, and therefore is lower than expected, whereas the “within one” score
incorporates the importance of “close” classifications on the ordinal scale. The
low FPR indicates that, in general, the other instances are not incorrectly labelled
as belonging to the class.
6.9 Classification results for the out of sample
database
The classification models constructed in the previous section were re-evaluated on
the out of sample database, using 10-fold cross validation.
Table 6.13 shows the confusion matrix for both classifiers for oedema. Table 6.14
shows the associated performance. The distinction between Normal and Mild sub-
jects is particularly subtle, and both classifiers labelled Normal subjects as Mild.
The “within one” score was 183 (98%) for Naive Bayes and 181 (96%) for Ada-
Boost.
Similarly, Table 6.15 shows the confusion matrix for both classifiers for infilt-
ration. Table 6.16 shows the associated performance. AdaBoost performed poorly
on Mild cases, with a TPR of 0.133. Naive Bayes performed well, with higher
TPR and comparable FPR, as compared to AdaBoost. The “within one” score
was 185 (99%) for Naive Bayes and 181 (96%) for AdaBoost.
ROC curves are shown for the Naive Bayes classifier using the out of sample
database in Figure 6.15 and Figure 6.16.
Overall, the results suggest that classification of oedema is more difficult than
infiltration (with the currently defined feature vectors). The figures on page 97
compare some of the feature spaces between the training database and the out
of sample database. Figure 6.10 and Figure 6.12 suggest that the general trend
for features 1 and 17 from the oedema vector were maintained between databases.
Figure 6.14 shows features 25 and 24 from the infiltration vector allow quite specific
clusters to form in the feature space, maintained between databases.
CHAPTER 6. CLASSIFICATION OF DISEASE SEVERITY 94
Class TPR FPR F-measure ROC area
Naive Bayes
0 (Normal) 0.708 0.031 0.739 0.968
1 (Mild) 0.636 0.133 0.677 0.877
2 (Moderate) 0.738 0.139 0.667 0.918
3 (Severe) 0.852 0.068 0.844 0.960
Weighted average 0.731 0.102 0.731 0.922
AdaBoost
0 (Normal) 0.917 0.012 0.917 0.997
1 (Mild) 0.818 0.125 0.800 0.925
2 (Moderate) 0.833 0.042 0.843 0.947
3 (Severe) 0.796 0.068 0.811 0.976
Weighted average 0.828 0.075 0.828 0.954
Table 6.10: Performance of oedema classification using the training database.
Real Naive Bayes AdaBoost
0 1 2 3 0 1 2 3
0 (Normal) 65 19 0 0 65 15 4 0
1 (Mild) 10 14 12 0 11 18 7 0
2 (Moderate) 1 10 27 10 4 5 36 3
3 (Severe) 0 0 4 14 0 0 7 11
Table 6.11: Confusion matrices for infiltration classification using the training
database.
Class TPR FPR F-measure ROC area
Naive Bayes
0 (Normal) 0.774 0.108 0.813 0.930
1 (Mild) 0.389 0.193 0.354 0.714
2 (Moderate) 0.563 0.116 0.593 0.882
3 (Severe) 0.778 0.060 0.667 0.979
Weighted average 0.645 0.122 0.653 0.881
AdaBoost
0 (Normal) 0.774 0.147 0.793 0.869
1 (Mild) 0.500 0.133 0.486 0.726
2 (Moderate) 0.750 0.130 0.706 0.880
3 (Severe) 0.611 0.018 0.688 0.946
Weighted average 0.699 0.128 0.701 0.851
Table 6.12: Performance of infiltration classification using the training database.
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Real Naive Bayes AdaBoost
0 1 2 3 0 1 2 3
0 (Normal) 0 5 0 1 0 6 0 0
1 (Mild) 3 17 4 0 1 17 2 4
2 (Moderate) 0 7 11 0 0 6 12 0
3 (Severe) 0 2 9 13 0 1 10 13
Table 6.13: Confusion matrices for oedema classification using the out of sample
database.
Class TPR FPR F-measure ROC area
Naive Bayes
0 (Normal) 0.000 0.045 0.000 0.321
1 (Mild) 0.708 0.292 0.618 0.780
2 (Moderate) 0.611 0.241 0.524 0.797
3 (Severe) 0.542 0.021 0.684 0.871
Weighted average 0.569 0.168 0.565 0.776
AdaBoost
0 (Normal) 0.000 0.015 0.000 0.467
1 (Mild) 0.708 0.271 0.630 0.781
2 (Moderate) 0.667 0.222 0.571 0.760
3 (Severe) 0.542 0.083 0.634 0.875
Weighted average 0.583 0.175 0.564 0.781
Table 6.14: Performance of oedema classification using the out of sample database.
In some cases it is difficult to ascertain if a relationship is maintained across
databases, in part due to the limited quantity of data-points. Allowance must
be made for the single-sample expert grading, which will have some unknown
variance. However, it is felt that in general, the rough location of clusters in the
feature space are maintained for each class.
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Real Naive Bayes AdaBoost
0 1 2 3 0 1 2 3
0 (Normal) 10 2 0 0 11 1 0 0
1 (Mild) 9 16 5 0 21 4 5 0
2 (Moderate) 1 5 10 2 5 0 13 0
3 (Severe) 0 0 0 12 0 0 4 8
Table 6.15: Confusion matrices for infiltration classification using the out of sample
database.
Class TPR FPR F-measure ROC area
Naive Bayes
0 (Normal) 0.833 0.167 0.625 0.878
1 (Mild) 0.533 0.167 0.604 0.775
2 (Moderate) 0.556 0.093 0.606 0.889
3 (Severe) 1.000 0.033 0.923 1.000
Weighted average 0.667 0.126 0.661 0.858
AdaBoost
0 (Normal) 0.917 0.433 0.449 0.874
1 (Mild) 0.133 0.024 0.229 0.676
2 (Moderate) 0.722 0.167 0.650 0.903
3 (Severe) 0.667 0.000 0.800 0.989
Weighted average 0.500 0.124 0.466 0.818
Table 6.16: Performance of infiltration classification using the out of sample data-
base.
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Figure 6.9: Oedema features 1 and 18
from the training database.
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Figure 6.10: Oedema features 1 and 18
from the out of sample database.
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Figure 6.11: Oedema features 17 and
18 from the training database.
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Figure 6.12: Oedema features 17 and
18 from the out of sample database.
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Figure 6.13: Infiltration features 25 and
34 from the training database.
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Figure 6.14: Infiltration features 25 and
34 from the out of sample database.
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Figure 6.15: ROC curves per class for Naive Bayes (oedema classification).
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Figure 6.16: ROC curves per class for Naive Bayes (infiltration classification).
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6.10 Conclusion
In this chapter, two feature vectors were designed with features from the joint
intensity space and the disease metrics (which were defined in Chapter 5). Auto-
matic classification using the out of sample database was successful with these
vectors. The results for the Naive Bayes classifier were marginally superior to
AdaBoost, especially with respect to the “within one” score. From these results,
it is clear that the joint intensity space of T1 and STIR signal contains sufficient
data to automatically classify disease state, both for oedema and fat infiltration.
Chapter 7
Conclusions
Very little literature exists that use computer-aided methods to approach disease
quantification or automatic diagnosis for inflammatory muscle disease (IIM). One
previous work attempted to fit a Gaussian distribution to the STIR signal intensity
histogram. However, when inflammatory muscle disease is suspected, the standard
protocol dictates that both T1 and STIR sequences be acquired such that the level
of oedema and fat infiltration may be assessed. When these sequences are acquired
with identical slice locations then it is known that the joint-intensity for muscle
tissue deviates in the presence of disease. Therefore, it is natural to assume (with
little to no alteration to the standard protocol) that both acquisitions may be
combined for superior analysis. However, with very little previous research to
build upon, the quantification methods presented in this work have been designed
with very few preconceptions, and therefore they are largely based on the expected
shape of the joint distribution. Confidence in the proposed methods is increased
for two reasons. First, the expected joint distribution is seen to deviate more for
subjects with increased disease, both for oedema and fat infiltration. Second, the
fundamental reason for signal intensity change is a result of composition changes
in the muscle tissue, with associated changes in physical properties, and hence the
altered signal response from the MRI scanner.
Since all scans in the databases have been obtained clinically, the methods
have been constructed with appreciation for the quality level expected from routine
clinical scans. In the hypothetical scenario where very high-quality MRI scans have
been obtained with no MR artefacts, it is assumed that the disease metrics would
be highly sensitive, if blood vessels are removed from consideration. However,
this is not practical in a clinical setting. The applicability of the quantification
methods proposed are much greater given that they have been constructed with
imperfect acquisitions and the fact that multiple MRI units have been utilised.
It is clear that any computer-aided analysis of MR data, for any pathology,
must be appropriately pre-processed due to a plethora of interacting physical phe-
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nomena present during acquisition. Without intensity correction methods, results
cannot be trusted as reliable or robust. In the work presented in this thesis,
the MRI scans have been very carefully pre-processed, especially with regards to
over-standardisation of intensity. The intensity scaling method presented was de-
signed directly from the need to compare joint histograms between subjects. Data
which are not useful for diagnosis, or may otherwise be confounding, have been
removed. For instance, a specialised tool has been designed to extract the femur
bone semi-automatically, where only one seed point is required per bone for the
entire set of slices. Although the method has only been tested on sets of 6 slices
over the upper leg region, it is expected that the method would work adequately
for a greater number of slices, or for a different body region, e.g. to extract the
humerus bone from scans of the upper arm. It may not work sufficiently for more
complex shapes such as the hip bone, since only one bone region is expected per
slice.
Within the research presented in this thesis, quantification methods for oedema
and fat infiltration have been designed and shown to have good positive correlation
with expert medical opinion. The oedema selection method used empirical tests
to find the approximate threshold size of contiguous objects in the initial region
selection that were not meaningful to the overall disease value. In validation test-
ing, the quantification methods have shown a good level of repeatability. However,
in general, quantification had considerable class overlap for both oedema and fat
infiltration problems. Class overlap may be exacerbated by the effect of a single
medical expert rater (with unknown variance) and the fact that only a single grade
is available per case of 6 slices. It is expected that some slices contain less disease
than others due to “patches” of disease, and therefore a range of disease quantities
per case is expected.
The proposed automatic classification of expert grade was highly successful,
particularly with regards to the out of sample results. Different regions of the joint
intensity space were useful in this respect and the results support the notion that
specific regions have diagnostic value. Naive Bayes performed marginally better
than AdaBoost (with J48), which may be due to the exact location of classes
in feature space that are inappropriately segmented by the J48 tree. In general,
classification of oedema was more difficult than classification of infiltration. This
is almost certainly due to higher SNR in T1 slices and the confounding nature of
blood vessels with MR artefacts and lower SNR in STIR slices.
It was shown that the semi-automatic quantification methods and automatic
classifiers will allow the systematic assessment of patients with suspected inflam-
matory muscle disease in a clinical setting. These methods will provide doctors
with robust and sensitive tools to measure disease state. In this way, it is ex-
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pected that the overall variation in disease assessment will be reduced. With
time, it is expected that the methods will improve and their use will become more
widespread.
The research conducted within the scope of this thesis has contributed to the
following publications. Further publications are planned in due course, as stated
below.
Published:
• James Jack, Terence Jones, Charles Hutchinson, Helmut Bez, and Eran Edir-
isinghe, ‘Automatic diagnosis of inflammatory muscle disease for MRI using
computer-extracted features of bivariate histograms’. Proceedings of the
International Society for Optics and Photonics, March 2015, pages 941402–
941402-7.
Planned:
• James Jack, Charles Hutchinson, and Eran Edirisinghe, ‘Computer-aided
quantification and automatic classification of inflammatory muscle disease
using clinically acquired MRI’. European Journal of Radiology. November
2015.
• James Jack, Eran Edirisinghe, and Charles Hutchinson, ‘Quantification of
oedema and fat infiltration for inflammatory muscle disease’. IEEE Trans-
actions on Medical Imaging. December 2015.
With respect to the above discussions, it can be seen that the aims set out
at the beginning have been achieved. However, some additional discussion on
possible enhancements and conclusions is warranted.
The joint histogram space potentially contains more powerful features than
those found with the current feature vectors. A thorough testing strategy over
hundreds of regions could have produced interesting results. It is assumed that
any feature vector will, on average, perform better over some regions of the joint
intensity space. However, this rigorous level of testing can have a negative impact
due to the possibility of over-fitting the data, and therefore it can only realistically
be conducted with a substantially larger dataset.
In order to train the system more thoroughly, it would be advantageous to
have multiple experts grade individual slices for oedema and fat infiltration. The
average grade could then be taken as a decimal figure. However, this would be
extremely laborious due to the total number of slices involved. Nevertheless, a
small scale trial would provide better validation of the proposed quantification
methods, particularly with regards to class overlap.
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Further validation using a much larger set of re-scanned subjects would be
highly beneficial, since it would allow the computation of confidence intervals for
each disease metric. Scans of control subjects on different MRI scanners would be
particularly useful.
The expert grade is a direct indication of the severity of oedema and fat in-
filtration found in the scan. This was done in order that the quantification and
classification methods could be tested fairly. However, in reality, there may be
other factors which affect the level of apparent disease. For instance, it may be
true that the elderly typically have a higher baseline level of fat infiltration, as
compared to the young adult. If this were the case, the original metrics could be
adjusted to account for the quantity of disease above the expected baseline level,
based on the age of the subject. For classification, it is possible that additional,
clinically-relevant features would increase the usefulness of the prediction. Note
that a new definition of “Normal” would be required, since it would no longer
reflect an absolute level.
The infiltration metric may not give accurate results when used on very ad-
vanced fat infiltration cases. This is a result of the segmentation method, based
on the joint histogram, and the physical changes which have taken place. Estim-
ating the original quantity of muscle in the leg prior to fat infiltration is a difficult
research question which should be addressed.
None of the databases included patients with juvenile myositis. Although the
method presented would in theory work for this type of disease, it has not been
tested. Ideally, another database of scans would be required to ascertain this
possibility.
The manual process of masking out blood vessels from the input scans (nor-
mally found on STIR sequences) could be replaced by an automatic process. Since
both blood vessels and oedema produce a hyperintense signal on STIR sequences,
the removal of all blood vessels prior to analysis would clearly be beneficial. How-
ever, it was found that automatic methods from the literature were particularly
prone to mislabelling oedema, or were otherwise erroneous due to the variability
in presentation or interaction of MR artefacts. Vessel pulsation, for instance, of-
ten causes hyperintense signal extending horizontally or vertically away from the
blood vessel, which may be selected as oedema. Therefore, blood vessel extraction
is a major confounding issue and requires further research.
The semi-automatic method to extract the femur bone from transverse slices
could be improved by being fully-automatic. It is assumed that an initial set of
thresholds with shape analysis could adequately identify an initial seed point.
References
[1] U. E. Aladl and T. Peters. ‘Medical image registration’. In: Multi Modality
State-of-the-Art Medical Image Segmentation and Registration Methodolo-
gies. Ed. by A. S. El-Baz et al. Vol. 2. Springer New York, 2011, pp. 227–
245. doi: 10.1007/978-1-4419-8204-9_9.
[2] F. J. Anscombe. ‘Graphs in statistical analysis’. In: The American Statisti-
cian 27.1 (Feb. 1973), p. 17. doi: 10.2307/2682899.
[3] M. L. Bartlett et al. ‘Quantitative assessment of myositis in thigh muscles
using magnetic resonance imaging’. In: Magnetic Resonance Imaging 17.2
(Feb. 1999), pp. 183–191. doi: 10.1016/S0730-725X(98)00092-7.
[4] P. Bearcroft. ‘Imaging modalities in the evaluation of soft tissue complaints’.
In: Best Practice & Research Clinical Rheumatology 21.2 (Apr. 2007), pp. 245–
259. doi: 10.1016/j.berh.2006.11.003.
[5] B. Belaroussi et al. ‘Intensity non-uniformity correction in MRI: existing
methods and their validation’. In: Medical Image Analysis 10.2 (Apr. 2006),
pp. 234–246. doi: 10.1016/j.media.2005.09.004.
[6] M. Boesen et al. ‘MRI quantification of rheumatoid arthritis: current know-
ledge and future perspectives’. In: European Journal of Radiology 71.2 (Aug.
2009), pp. 189–196. doi: 10.1016/j.ejrad.2009.04.048.
[7] H. Brighton and G. Gigerenzer. ‘The bias bias’. In: Journal of Business
Research 68.8 (Aug. 2015), pp. 1772–1784. doi: 10.1016/j.jbusres.2015.
01.061. (Visited on 21/09/2015).
[8] M. Brown and R. Semelka. MRI: basic principles and applications. 3rd ed.
John Wiley & Sons, 2003.
[9] G. Brys, M. Hubert and A. Struyf. ‘A robust measure of skewness’. In:
Journal of Computational and Graphical Statistics 13.4 (Dec. 2004), pp. 996–
1017. doi: 10.1198/106186004X12632.
[10] J. Cheng and R. Greiner. ‘Comparing Bayesian network classifiers’. In: Pro-
ceedings of the fifteenth conference on uncertainty in artificial intelligence.
Morgan Kaufmann Publishers Inc., 1999, pp. 101–108.
104
REFERENCES 105
[11] C. Damgaard and J. Weiner. ‘Describing inequality in plant size or fecund-
ity’. In: Ecology 81.4 (2000), pp. 1139–1142. doi: 10.1890/0012-9658(2000)
081[1139:DIIPSO]2.0.CO;2.
[12] B. M. Dawant, A. P. Zijdenbos and R. Margolin. ‘Correction of intensity
variations in MR images for computer-aided tissue classification’. In: Medical
Imaging, IEEE Transactions on 12.4 (1993), pp. 770–781. doi: 10.1109/
42.251128.
[13] L. R. Dice. ‘Measures of the amount of ecologic association between species’.
In: Ecology 26.3 (July 1945), p. 297. doi: 10.2307/1932409.
[14] M. M. Dimachkie. ‘Idiopathic inflammatory myopathies’. In: Journal of
Neuroimmunology 231.1-2 (Feb. 2011), pp. 32–42. doi: 10.1016/j.jneuroim.
2010.10.013.
[15] K. Doi. ‘Computer-aided diagnosis in medical imaging: historical review,
current status and future potential’. In: Computerized Medical Imaging and
Graphics 31.4-5 (June 2007), pp. 198–211. doi: 10.1016/j.compmedimag.
2007.02.002.
[16] H. Ellis, B. M. Logan and A. Dixon. Human sectional anatomy: atlas of body
sections, CT and MRI images. 3rd ed. London: Hodder-Arnold, 2007.
[17] A. Elnakib et al. ‘Medical image segmentation: a brief survey’. In: Multi Mod-
ality State-of-the-Art Medical Image Segmentation and Registration Method-
ologies. Ed. by A. S. El-Baz et al. Vol. 2. Springer New York, 2011, pp. 1–39.
doi: 10.1007/978-1-4419-8204-9_1.
[18] T. Fawcett. ‘An introduction to ROC analysis’. In: Pattern Recognition Let-
ters 27.8 (June 2006), pp. 861–874. doi: 10.1016/j.patrec.2005.10.010.
[19] A. Fischmann et al. ‘Quantitative MRI can detect subclinical disease pro-
gression in muscular dystrophy’. In: Journal of Neurology 259.8 (Aug. 2012),
pp. 1648–1654. doi: 10.1007/s00415-011-6393-2.
[20] J. Flusser and B. Zitova´. ‘A comment on “a novel approach for the regis-
tration of weak affine images”’. In: Pattern Recognition Letters 34.12 (Sept.
2013), pp. 1381–1385. doi: 10.1016/j.patrec.2013.04.024.
[21] A. F. Frangi et al. ‘Multiscale vessel enhancement filtering’. In: Medical im-
age computing and computer-assisted interventation—MICCAI’98. Springer,
1998, pp. 130–137. doi: 10.1007/BFb0056195.
[22] Y. Freund and R. E. Schapire. ‘Experiments with a new boosting algorithm’.
In: Machine Learning: Proceedings of the Thirteenth International Confer-
ence. Vol. 96. 1996, pp. 148–156.
REFERENCES 106
[23] A. A. Goshtasby. Image registration principles, tools and methods. London:
Springer London, 2012.
[24] M. A. Hall. ‘Correlation-based feature subset selection for machine learning’.
PhD thesis. Hamilton, New Zealand: University of Waikato, 1998.
[25] J. A. Hanley and B. J. McNeil. ‘The meaning and use of the area under a
receiver operating characteristic (ROC) curve.’ In: Radiology 143.1 (1982),
pp. 29–36. doi: 10.1148/radiology.143.1.7063747.
[26] R. H. Hashemi. MRI: the basics. 3rd ed. Philadelphia, PA: Lippincott Wil-
liams & Wilkins, 2010.
[27] P. Hellier. ‘Consistent intensity correction of MR images’. In: Proc. Interna-
tional Conference on Image Processing 2003. Vol. 1. IEEE, 2003, pp. 1109–
1112. doi: 10.1109/ICIP.2003.1247161.
[28] R. E. Hendrick. ‘The AAPM/RSNA physics tutorial for residents. Basic
physics of MR imaging: an introduction.’ In: RadioGraphics 14.4 (July 1994),
pp. 829–846. doi: 10.1148/radiographics.14.4.7938771.
[29] J. W. Hennel. A primer of magnetic resonance imaging. London : River
Edge, NJ: Imperial College Press; Distributed by World Scientific Pub. Co,
1997.
[30] S. Herlidou et al. ‘Comparison of automated and visual texture analysis
in MRI: characterization of normal and diseased skeletal muscle’. In: Mag-
netic Resonance Imaging 17.9 (1999), pp. 1393–1397. doi: 10.1016/S0730-
725X(99)00066-1.
[31] G. Hermosillo et al. ‘Image registration in medical imaging: applications,
methods, and clinical evaluation’. In: Multi Modality State-of-the-Art Med-
ical Image Segmentation and Registration Methodologies. Ed. by A. S. El-Baz
et al. Vol. 2. Springer New York, 2011, pp. 263–313. doi: 10.1007/978-1-
4419-8204-9_11.
[32] D. Hill et al. ‘Medical image registration’. In: Physics in Medicine and Bio-
logy 46.3 (2001), R1–R45. doi: 10.1088/0031-9155/46/3/201.
[33] Z. Hou. ‘A review on MR image intensity inhomogeneity correction’. In:
International Journal of Biomedical Imaging 2006 (2006), pp. 1–11. doi:
10.1155/IJBI/2006/49515.
[34] C. Hutchinson. A model radiologist. Inaugural lecture. University Hospital
Coventry and Warwickshire, Jan. 2013. url: http://www2.warwick.ac.
uk/fac/med/news/events/inaugural/archive/2013/chutchinson/
(visited on 19/08/2013).
REFERENCES 107
[35] K. Hynynen et al. ‘Temperature monitoring in fat with MRI’. In: Magnetic
Resonance in Medicine 43.6 (June 2000), pp. 901–904. doi: 10.1002/1522-
2594(200006)43:6<901::AID-MRM18>3.0.CO;2-A.
[36] P. Jaccard. ‘The distribution of the flora in the alpine zone’. In: New Phyto-
logist 11.2 (1912), pp. 37–50. doi: 10.1111/j.1469-8137.1912.tb05611.x.
[37] J. Jack et al. ‘Automatic diagnosis of inflammatory muscle disease for MRI
using computer-extracted features of bivariate histograms’. In: Proc. SPIE.
Vol. 9414. Orlando, Florida, United States: International Society for Optics
and Photonics, Mar. 2015, pp. 941402–941402-7. doi: 10.1117/12.2076757.
[38] F. Ja¨ger and J. Hornegger. ‘Nonrigid registration of joint histograms for
intensity standardization in magnetic resonance imaging’. In: IEEE Trans-
actions on Medical Imaging 28.1 (Jan. 2009), pp. 137–150. doi: 10.1109/
TMI.2008.2004429.
[39] F. Ja¨ger et al. ‘A new method for MRI intensity standardization with applic-
ation to lesion detection in the brain’. In: Vision Modeling and Visualization.
Ed. by L. Kobbelt et al. Berlin: Aka GmBH, 2006, pp. 269–276.
[40] T. Jerman et al. ‘Beyond Frangi: an improved multiscale vesselness filter’.
In: Proc. SPIE. Vol. 9413. Orlando, Florida, United States: International
Society for Optics and Photonics, 2015, 94132A–94132A-11. doi: 10.1117/
12.2081147.
[41] Z. Ji et al. ‘Generalized rough fuzzy c-means algorithm for brain MR image
segmentation’. In: Computer Methods and Programs in Biomedicine 108.2
(Nov. 2012), pp. 644–655. doi: 10.1016/j.cmpb.2011.10.010.
[42] A. Kassner and R. E. Thornhill. ‘Texture analysis: a review of neurologic MR
imaging applications’. In: American Journal of Neuroradiology 31.5 (May
2010), pp. 809–816. doi: 10.3174/ajnr.A2061.
[43] F. Khalifa et al. ‘State-of-the-art medical image registration methodologies:
a survey’. In: Multi Modality State-of-the-Art Medical Image Segmentation
and Registration Methodologies. Ed. by A. S. El-Baz et al. Vol. 1. Springer
US, 2011, pp. 235–280. doi: 10.1007/978-1-4419-8195-0_9.
[44] H. K. Kim et al. ‘T2 mapping in Duchenne muscular dystrophy: distribution
of disease activity and correlation with clinical assessments’. In: Radiology
255.3 (2010), pp. 899–908. doi: 10.1148/radiol.10091547.
[45] J. J. Kim et al. ‘The utility of magnetic resonance imaging in inflammatory
myopathy’. In: Journal of Rheumatic Diseases 20.5 (2013), p. 297. doi:
10.4078/jrd.2013.20.5.297.
REFERENCES 108
[46] T. Ko¨nig et al. ‘Ultrasound texture-based CAD system for detecting neur-
omuscular diseases’. In: International Journal of Computer Assisted Radi-
ology and Surgery 10.9 (Sept. 2015), pp. 1493–1503. doi: 10.1007/s11548-
014-1133-6.
[47] C. Ko¨se, O. Genc¸aliog˘lu and U. S¸evik. ‘An automatic diagnosis method for
the knee meniscus tears in MR images’. In: Expert Systems with Applications
36.2 (Mar. 2009), pp. 1208–1216. doi: 10.1016/j.eswa.2007.11.036.
[48] C. Lo et al. ‘Effect of magnetic resonance imaging on core body temperature
in anaesthetised children’. In: Anaesthesia and Intensive Care 42.3 (2014),
pp. 333–339. url: http://www.aaic.net.au/Document/?D=20120359
(visited on 17/07/2015).
[49] T. Y. Lu, K. P. Ng and D. A. Isenberg. ‘Inflammatory muscle disease as-
sessment’. In: Current rheumatology reports 10.4 (2008), pp. 328–332. doi:
10.1007/s11926-008-0052-3.
[50] A. Madabhushi and J. K. Udupa. ‘Interplay between intensity standard-
ization and inhomogeneity correction in MR image processing’. In: IEEE
Transactions on Medical Imaging 24.5 (May 2005), pp. 561–576. doi: 10.
1109/TMI.2004.843256.
[51] J. B. A. Maintz and M. A. Viergever. ‘A survey of medical image registra-
tion’. In: Medical Image Analysis 2.1 (Mar. 1998), pp. 1–36. doi: 10.1016/
S1361-8415(01)80026-8.
[52] A. C. Mamourian. Practical MR physics: and case file of MR artifacts and
pitfalls. New York: Oxford University Press, 2010.
[53] D. Messineo et al. ‘MRI in the study of distal primary myopathopies and
of muscular alterations due to peripheral neuropathies: possible diagnostic
capacities of MR equipment with low intensity field (0.2 T) dedicated to
peripheral limbs’. In: Magnetic Resonance Imaging 16.7 (1998), pp. 731–
741. doi: 10.1016/S0730-725X(98)00080-0.
[54] B. Milanovic. ‘A simple way to calculate the Gini coefficient, and some
implications’. In: Economics Letters 56.1 (1997), pp. 45–49. doi: 10.1080/
1350485032000100279.
[55] L. G. Nyu´l and J. K. Udupa. ‘An approach to standardizing MR image
intensity scale’. In: Proc. SPIE. Vol. 3658. San Diego, California, United
States: International Society for Optics and Photonics, Feb. 1999, pp. 595–
603. doi: 10.1117/12.349472.
REFERENCES 109
[56] L. G. Nyu´l and J. K. Udupa. ‘On standardizing the MR image intensity
scale’. In: Magnetic Resonance in Medicine 42.6 (Dec. 1999), pp. 1072–1081.
doi: 10.1002/(SICI)1522-2594(199912)42:6<1072::AID-MRM11>3.0.
CO;2-M.
[57] L. G. Nyu´l, J. K. Udupa and X. Zhang. ‘New variants of a method of
MRI scale standardization’. In: Medical Imaging, IEEE Transactions on 19.2
(2000), pp. 143–150. doi: 10.1109/42.836373.
[58] M. Petre´n-mallmin et al. ‘The effect of temperature on MR relaxation times
and signal intensities for human tissues’. In: MAGMA Magnetic Resonance
Materials in Physics, Biology, and Medicine 1.3-4 (Sept. 1993), pp. 176–184.
doi: 10.1007/BF01769420.
[59] R. A. Pooley. ‘Fundamental physics of MR imaging’. In: RadioGraphics 25.4
(July 2005), pp. 1087–1099. doi: 10.1148/rg.254055027.
[60] J. R. Quinlan. C4.5: programs for machine learning. San Francisco, CA,
USA: Morgan Kaufmann Publishers Inc., 1993.
[61] B. Ramakrishna et al. ‘An automatic computer-aided detection system for
meniscal Tears on magnetic resonance images’. In: IEEE Transactions on
Medical Imaging 28.8 (Aug. 2009), pp. 1308–1316. doi: 10 . 1109 / TMI .
2009.2014864.
[62] G. X. Ritter and J. N. Wilson. Handbook of computer vision algorithms in
image algebra. 2nd ed. Boca Raton: CRC Press, 2001.
[63] N. Robitaille et al. ‘Tissue-based MRI intensity standardization: application
to multicentric datasets’. In: International Journal of Biomedical Imaging
2012 (2012), pp. 1–11. doi: 10.1155/2012/347120.
[64] A. Roche et al. ‘The correlation ratio as a new similarity measure for mul-
timodal image registration’. In: Medical Image Computing and Computer-
Assisted Interventation (MICCAI98). Springer, 1998, pp. 1115–1124. url:
http : / / dl . acm . org / citation . cfm ? id = 646921 . 709612 (visited on
09/02/2013).
[65] J. G. Sled, A. P. Zijdenbos and A. C. Evans. ‘A nonparametric method for
automatic correction of intensity nonuniformity in MRI data’. In: Medical
Imaging, IEEE Transactions on 17.1 (1998), pp. 87–97. doi: 10.1109/42.
668698.
[66] Y. Tong et al. ‘Interactive non-uniformity correction and intensity standard-
ization of MR images’. In: Proc. SPIE. Vol. 9415. Orlando, Florida, United
States: International Society for Optics and Photonics, Mar. 2015, 94151N–
94151N-6. doi: 10.1117/12.2082878.
REFERENCES 110
[67] N. J. Tustison et al. ‘N4ITK: improved N3 bias correction’. In: IEEE Trans-
actions on Medical Imaging 29.6 (June 2010), pp. 1310–1320. doi: 10.1109/
TMI.2010.2046908.
[68] J. Van De Vlekkert et al. ‘Combining MRI and muscle biopsy improves
diagnostic accuracy in subacute-onset idiopathic inflammatory myopathy:
combining MRI and muscle biopsy in IIM’. In: Muscle & Nerve 51.2 (Feb.
2015), pp. 253–258. doi: 10.1002/mus.24307.
[69] D. J. Vining and G. W. Gladish. ‘Receiver operating characteristic curves:
a basic understanding.’ In: Radiographics 12.6 (1992), pp. 1147–1154. doi:
10.1148/radiographics.12.6.1439017.
[70] U. Vovk, F. Pernus and B. Likar. ‘A review of methods for correction of
intensity inhomogeneity in MRI’. In: IEEE Transactions on Medical Imaging
26.3 (Mar. 2007), pp. 405–421. doi: 10.1109/TMI.2006.891486.
[71] S. Wang and R. M. Summers. ‘Machine learning and radiology’. In: Medical
Image Analysis 16.5 (July 2012), pp. 933–951. doi: 10.1016/j.media.
2012.02.005.
[72] D. Weishaupt, V. D. Ko¨chli and M. Borut. How does MRI work? An intro-
duction to the physics and function of magnetic resonance imaging. Trans-
lated from German. Berlin; New York: Springer, 2006.
[73] X. Wu et al. ‘Top 10 algorithms in data mining’. In: Knowledge and Inform-
ation Systems 14.1 (Jan. 2008), pp. 1–37. doi: 10.1007/s10115-007-0114-
2.
[74] T. S. Yoo. Insight into images: principles and practice for segmentation,
registration, and image analysis. Wellesley, Mass.: A K Peters, 2004.
[75] Z. Zeng and R. Zwiggelaar. ‘Joint histogram modelling for segmentation
multiple sclerosis lesions’. In: Computer Vision/Computer Graphics Col-
laboration Techniques. Springer Berlin Heidelberg, 2011, pp. 133–144. doi:
10.1007/978-3-642-24136-9_12.
[76] Y. Zhang et al. ‘Medical image segmentation using new hybrid level-set
method’. In: Fifth International Conference BioMedical Visualization. Lon-
don: IEEE, July 2008, pp. 71–76. doi: 10.1109/MediVis.2008.12.
[77] B. Zitova´ and J. Flusser. ‘Image registration methods: a survey’. In: Image
and Vision Computing 21.11 (Oct. 2003), pp. 977–1000. doi: 10.1016/
S0262-8856(03)00137-9.
Glossary
AD Alzheimer’s Disease.
ADNI The Alzheimer’s Disease Neuroimaging Initiative (ADNI) is a large data-
base of MRI scans and associated medical data.
AUC Area Under the Curve.
AUROC Area Under the Receiver Operating characteristic Curve.
CAD Computer Aided Detection or Computer Aided Diagnosis.
CADe Computer Aided Detection.
CADx Computer Aided Diagnosis.
CC Correlation Coefficient. A registration measure.
CK Creatine Kinase. A type of blood serum test.
CR Correlation Ratio. A registration measure.
CT Computed Tomography (X-ray).
DICOM The Digital Imaging and Communications in Medicine standard.
FNR False Negative Rate.
FOV Field of View.
FPR False Positive Rate.
FT Fourier Transform.
GLCM The Gray-Level Co-occurrence Matrix describes the number of trans-
itions in gray-level between two pixels at a set distance and direction over
an image.
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IIM Idiopathic Inflammatory Myopathies. A group of systemic diseases with
unknown cause.
infiltration Infiltration of muscle tissue (by fat).
IOI Intensity of Interest.
ITK Insight segmentation and registration ToolKit. An open source project for
segmentation and registration. Available at: www.itk.org
MI Mutual Information. A registration measure.
MR Magnetic Resonance.
MRI Magnetic Resonance Imaging.
myopathy Muscle disease.
myositis A muscle disease of unknown cause, characterised by inflammation and
muscle weakness.
oedema Inflammation or swelling; a build up of fluid in the body’s tissues.
PDF Probability Density Function.
prevalence The prevalence is the proportion of a population that had a given
disease, as measured at a certain point in time.
RF Radio Frequency. Part of the electromagnetic spectrum.
RLM Run-Length Matrix.
ROC Receiver Operating Characteristic.
ROI Region Of Interest.
sagittal The cardinal plane that goes from front to back, dividing a person into
left and right halves.
sensitivity The percentage of real positive cases correctly identified as positive.
serum The component of blood without red blood cells, white blood cells, or
clotting factor (fibrinogen).
SNR Signal to Noise Ratio. High signal to noise ratio is better.
specificity The percentage of real negative cases correctly identified as negative.
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STIR A type of MRI imaging sequence: Short TI Inversion Recovery. The signal
from fat is suppressed.
SVM Support Vector Machine.
T1 A type of MRI imaging sequence. It measures longitudinal relaxation.
T2 A type of MRI imaging sequence. It measures transverse relaxation.
TE Time to Echo. The amount of time to wait before measuring an echo from
the RF pulse.
TPR True Positive Rate.
TR Time to Repeat. The amount of time to wait between RF pulses.
transverse The cardinal plane that divides the body into upper and lower parts.
US Ultrasound.
